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ABSTRACT
The integrity of genomic DNA is constantly challenged by endogenous and
environmental agents with the formation of DNA adducts. Some of these adducts are
toxic and mutagenic to replication, thus potentially leading to cancer and other genetic
diseases. To counteract the undesired DNA modifications from damaging agents,
cells have evolved a number of repair pathways, such as base-excision repair,
nucleotide-excision repair, mismatch repair, and direct reversal repair, to restore the
intact DNA. However, DNA repair is not always efficient, there are many interfering
factors, such as inherited deficiency in DNA repair pathways, or the abnormal uptake
of substance with inhibitory effects to DNA repair enzymes that may result in the
accumulation of DNA adducts. In the meantime, cells have equipped with mechanisms
to carry out translesion bypass of DNA adducts, and the bypass of these adducts may
lead to mutagenesis. Therefore, studying the DNA adduct formation, repair, and other
mutagenic consequences can shed light on how DNA damaging agents impact on
cellular response of organisms. A comprehensive understanding of the biological
outcomes of interested DNA adducts requires the development of a set of efficient
chemical

approaches

to

prepare

and

characterize

adduct-containing

DNA

oligonucleotides. On the other hand, the biological evaluation of these DNA adducts
from various aspects, such as studying their genotoxic effects, and exploring potential
interfering factors to their cellular repair, is essential for providing insights into the
etiology of many diseases including cancer.
This dissertation describes the chemical synthesis, characterization, and
biological evaluation of methylation and glycation DNA adducts by using a variety of

chemical and genetic tools. These strategies along with the findings obtained from the
application of them are briefly discussed in the abstract of four manuscripts as
following, and are described in detail in CHAPTER 1, 2, 3, and 4.
In MANUSCRIPT-I, the objective of this study was to develop a rigorous
procedure to chemically synthesize and characterize adduct-containing DNA
oligonucleotides for biological studies. Oligonucleotides serve as important tools for
biological, chemical, and clinical research. The preparation of oligonucleotides
through automated solid-phase synthesis is well-established. However, identification
of byproducts generated from DNA synthesis, especially from oligonucleotides
containing site-specific modifications, is sometimes challenging. Typical highperformance liquid chromatography, mass spectrometry, and gel electrophoresis
methods alone are not sufficient for characterizing unexpected byproducts, especially
for those having identical or very similar molecular weight to the products. We
developed a rigorous quality control procedure to characterize byproducts generated
during oligonucleotide syntheses: (1) purify oligonucleotides by different HPLC
systems; (2) determine exact molecular weight by high-resolution MS; (3) locate
modification position by MS/MS or exonuclease digestion with matrix-assisted laser
desorption ionization-time of flight analysis; and (4) conduct, where applicable,
enzymatic assays. We applied these steps to characterize byproducts in the syntheses
of oligonucleotides containing biologically important methyl DNA adducts 1methyladenine and 3-methylcytosine. In 1-methyladenine synthesis, we differentiated
a regioisomeric byproduct 6-methyladenine, which possesses a molecular weight
identical to uncharged 1-methyladenine. As for 3-methylcytosine, we identified a

deamination byproduct 3-methyluracil, which is only 1 Da greater than uncharged 3methylcytosine in the ∼4900 Da context. The detection of these byproducts would be
very challenging if the abovementioned procedure was not adopted.
In MANUSCRIPT-II, as we have developed a platform enabling us to conduct in
vitro synthesis and quality control of interested DNA adducts, we synthesized a
number of N-methyl DNA adducts occurring at the Watson-Crick base-pairing face of
the four nucleobases including 1-methyladenine, 3-methylcytosine, 1-methylguanine,
and 3-methylthymine. We evaluated the repair preference of AlkB family DNA repair
enzymes on these N-methyl DNA adducts under difference strand context. The AlkB
protein is a repair enzyme that uses an α-ketoglutarate/Fe(II)-dependent mechanism to
repair alkyl DNA adducts. AlkB has been reported to repair highly susceptible
substrates, such as 1-methyladenine and 3-methylcytosine, more efficiently in single
strand-DNA than in double strand-DNA. Here, we tested the repair of weaker AlkB
substrates 1-methylguanine and 3-methylthymine and found that AlkB prefers to
repair them in double strand-DNA. We also discovered that AlkB and its human
homologues, ALKBH2 and ALKBH3, are able to repair the aforementioned adducts
when the adduct is present in a mismatched base pair. These observations demonstrate
the strong adaptability of AlkB toward repairing various adducts in different
environments.
In MANUSCRIPT-III, we aimed to explore the potential interfering effects of
the overconsumption of substance from environmental resources to DNA repair. We
studied the inhibitory activity of a class of natural products, hydrolysable tannins, on
ALKBH2 enzyme. Hydrolysable tannins are a class of polyphenolic compounds

commonly found in many plants. In this work, we studied the in vitro inhibitory
mechanism of six molecules on ALKBH2. We determined the IC50 values of these
compounds on the repair of 3-methylcytosine, the proto-typical substrate of ALKBH2.
A structure-activity relationship was also observed between the strength of inhibition
and the number of galloyl moieties in a molecule. In addition, we found that the
inhibition by this class of polyphenolic compounds on ALKBH2 is through an ironchelating mechanism. Direct reversal of alkyl DNA adducts by AlkB family enzymes
constitute an important cellular repair mechanism for maintaining genome integrity.
We here demonstrated that the potential effect of overdosing hydrolysable tannins
might lead to the inhibition of iron-dependent AlkB family enzymes.
In MANUSCRIPT-IV, the objective of this work was to explore the in vitro
synthesis and the in cell biological outcomes of glycation DNA adducts generated
from cellular reducing sugar glucose-6-phosphate. We chemically synthesized and
characterized the Amadori glycation products from glucose-6-phosphate and evaluated
their toxic and mutagenic properties in cell. Reducing sugars and their metabolic
derivatives (e.g. D-glucose, D- glucose-6-phosphate, methylglyoxal, and glyoxal) can
non-enzymatically react with cellular biomacromolecules, such as proteins and nucleic
acids, to induce glycation. Glucose and glucose-6-phosphate have been shown to
glycate lysine residues of protein to form Amadori adducts. As a glycating agent with
multiple-fold higher reactivity and much more abundant cellular concentration than
glucose, glucose-6-phosphate has also been proposed to glycate DNA and cause
genotoxicity with the formation of Amadori adducts. Due to the unstable nature of
Amadori DNA adducts and a number of potential repair pathways, it is challenging to

study their toxic and mutagenic properties in cell. Therefore, the specific biological
outcomes of these adducts remain unclear.

In this work, we used a number of

chemical and genetic approaches and studied the biological consequences, such as
replication block and mutations, of Amadori DNA adducts in a site-specific manner.
Our data showed that Amadori DNA adducts arising from glucose-6-phosphate can
induce G to T and single nucleotide deletion, which may lead to devastating biological
consequences if left unrepaired, thereby affecting the genome integrity of organisms.
In summary, this dissertation offers a systematic strategy to conduct both in vitro
and in cell studies of DNA adducts and mutagenesis. The methods applied in this work
will not only broaden the basic research for chemical modification of nucleic acids,
but also bring new aspects for studying DNA biology.
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PREFACE
This dissertation was written according to the University of Rhode Island
“Guidelines for the Format of Theses and Dissertations” standards for manuscript
format. This dissertation comprises of four manuscripts that have been combined to
meet the degree requirements of the Department of Biomedical and Pharmaceutical
Sciences, College of Pharmacy, University of Rhode Island.
Two manuscripts have been published under the following titles:
I.

Characterization of byproducts from chemical syntheses of oligonucleotides
containing 1-methyladenine and 3-methylcytosine.
Published on ACS OMEGA 2017, 2, 8205-8212

II.

Adaptive response enzyme AlkB preferentially repairs 1-methylguanine and 3methylthymine adducts in double-stranded DNA.
Published on Chemical Research in Toxicology 2016, 29, 687-693
Two additional manuscripts will be submitted under the following titles:

III.

Hydrolysable tannins are iron chelators that inhibit AlkB family DNA repair
enzyme ALKBH2.
Submitted on Chemical Research in Toxicology

IV.

Guanine DNA glycation by glucose 6-phosphate induces G to T mutation and
single nucleotide deletion in cell
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ABSTRACT
Oligonucleotides serve as important tools for biological, chemical, and medical
research.

The preparation of oligonucleotides through automated solid-phase

synthesis is well established. However, identification of byproducts generated from
DNA

synthesis,

especially

from

oligonucleotides

modifications, is sometimes challenging.

containing

site-specific

Typical HPLC, Mass Spectrometry (MS),

and gel electrophoresis methods alone are not sufficient for characterizing unexpected
byproducts, especially for those having identical or very similar molecular weight
(MW) to the products. We used a rigorous quality control procedure to characterize
byproducts generated during oligonucleotide syntheses: 1) purify oligonucleotide by
different HPLC systems; 2) determine the exact MW by high resolution MS; 3) locate
modification position by MS/MS or exonuclease digestion with MALDI-TOF
analysis; and 4) conduct, where applicable, enzymatic assays. We applied these steps
to characterize byproducts in the syntheses of oligonucleotides containing important
methyl DNA adducts 1-methyladenine (m1A) and 3-methylcytosine (m3C). In m1A
synthesis, we differentiated a regioisomeric byproduct 6-methyladenine, which
possesses identical MW to m1A. As for m3C, we identified a deamination byproduct
3-methyluracil, which is only 1 Dalton greater than m3C in the ~ 4,900 Dalton
context.

The detection of these byproducts would be very challenging if the

abovementioned procedure were not adopted.
INTRODUCTION
Oligonucleotides synthesized chemically are widely used as drugs and research
tools in biology, chemistry, and medicine. Solid phase synthesis of DNA and RNA
2

oligonucleotides has been well developed and automated phosphoramidite-based
chemical process has become highly efficient.1–3 Phosphoramidites of regular and
some modified nucleotides are commercially available and certain oligonucleotide
strands could be readily obtained from commercial sources.4–7 Besides the great
development in the synthesis of oligonucleotides, the differentiation of byproducts
from the product oligonucleotides, especially on those containing site-specifically
modified structures, is sometimes ignored by the end users. If those byproducts or
small impurities were not identified and removed, it could have devastating
consequences for the corresponding biological assays and medical treatments.8,9 For
certain instances, it is challenging to identify some byproducts generated in the
synthesis and deprotection steps, especially those byproducts that have identical or
very similar MW to the desired product oligonucleotide.
We have synthesized various oligonucleotides containing modified structures in
the past, focusing on alkyl or aryl DNA adducts, by using solid and solution phase
DNA synthesis.10–14 In the syntheses of oligonucleotides containing 1-methyladenine
(m1A) and 3-methylcytosine (m3C), we observed byproducts are either regioisomer
(identical MW) to the product or have 1 Dalton in MW greater than the product in a ~
4,900 Dalton context (Figure 1a). m1A and m3C are formed by exogenous and
endogenous alkylating agents mainly in single-stranded DNA and have been detected
both in vitro15–21 and in vivo15,20,22–29. Both adducts are cytotoxic and block DNA
replication, and are the best substrates for the AlkB family DNA repair enzymes
(Figure 1b).30–34 m3C has also been proposed an epigenetic biomarker for cancer.35

3

Most of our DNA syntheses successfully provided target oligonucleotides.
However, some oligonucleotides contained side reaction contaminants generated
during the synthesis or deprotection steps, requiring further purification and
identification. To that end, we applied a rigorous quality control process which entails
the following steps: i) Synthesize an adduct-containing oligonucleotide from the
corresponding phosphoramidite; ii) purify the product oligonucleotide by both reverse
phase and anion exchange HPLC; iii) measure the exact MW of the oligonucleotide by
high resolution MS (HR-MS), certain impurities can also be detected by HR-MS; iv)
determine the modification position by either MS/MS or exonuclease digestion with
MALDI-TOF analysis; and v) test the biological activity of the adduct-containing
oligonucleotide by appropriate enzymatic assays. We are assuming that the modified
nucleotide has been extensively investigated for its stability under solid-phase
chemical synthesis and deprotection beforehand; however, the strategy outlined above
should confirm this. Nuclear Magnetic Resonance (NMR; 1H,

13

C, and

31

P) is a

powerful tool for structural integrity studies of the phosphoramidite on the milligram
scale.36–38 However, NMR becomes impractical for characterizing minor impurities
within the modified structures in synthetic oligonucleotides due to increasing spectral
complexity, as well as the final amount of material available (e.g. on a micro-mole or
less scale).

Below, we report the detailed characterization of byproducts in the

syntheses of oligonucleotides containing m1A and m3C. The characterization and
separation of those byproducts provides confidence in the quality of oligonucleotides
used in further biological experiments.
EXPERIMENTAL SECTION
4

Synthesis of Oligonucleotides Containing m1A and m3C. Oligonucleotides
(16mer) with the sequence 5’-GAAGACCTXGGCGTCC-3’ containing the lesions at
X position were made by using solid-phase phosphoramidite chemistry on a
MerMade-4 Oligonucleotide Synthesizer.10,34,39 The phosphoramidites were purchased
from ChemGenes. N1-Methyl deoxyadenosine (n-fmoc) phosphoramidite was used
for m1A synthesis. N3-Methyl deoxycytidine (n-bz) phosphoramidite was used for
m3C synthesis. The final cleavage and deprotection step was usually carried out by
treating the oligonucleotide with concentrated aqueous ammonium hydroxide (28%) at
80 ℃ for 3 hours. The modified cleavage and deprotection step for minimizing the
byproduct formation was at 25℃ for 16 h. The concentration of an oligonucleotide
was determined by measuring UV absorbance at 260 nm. The extinction coefficient (ε)
of a certain adduct is calculated as its unmodified counterpart due to the slight
variation between the values in the context of a 16mer DNA.
Purity Test of Oligonucleotides Containing m1A and m3C and Related
Byproducts by HPLC. The purity of oligonucleotides was tested by both reverse
phase (C18) and anion exchange HPLC methods. For the reverse phase test, liquid
chromatographic separation was performed by using a Phenomenex Luna SemiPreparative C18 column (9 x 250 mm, 5 µm) at a flow rate of 3 mL/min. Solvent A
was 100 mM triethylammonium acetate in water and solvent B was 100% acetonitrile.
A solvent gradient was carried out under the following conditions: 2.0% of B for 0.2
min, 2.0 to 9.0% of B over 0.3 min, 9.0 to 9.4% of B over 16 min, 9.4 to 70.0% of B
over 0.5 min, 70.0% of B for 3 min, 70.0 to 2.0% of B over 0.5 min, and 2.0 % B over
4.5 min. The column oven was set at 40 ℃. The UV signal at 260 nm was used to
5

detect the oligonucleotide absorbance.

For the anion exchange LC analysis,

oligonucleotides were purified and tested by using a Thermo DNAPac PA-100 anion
exchange column (4 x 250 mm, 13 µm) with solvent A as water and solvent B as 1.5
M ammonium acetate in water.

A solvent gradient was carried out under the

following conditions: 50.0% of B for 1 min, 50.0 to 52.0% of B over 2 min, 52.0 to
75.0% over 1 min, 75.0% of B for 2 min, 75.0 to 50.0% of B over 0.5 min, and 50.0%
of B for 4.5 min. The flow rate was at 4.0 ml/min.
HPLC-MS Analysis. High resolution MS analyses of oligonucleotides were
performed on AB Sciex triple quadrupole-TOF mass spectrometers (ABI4600 and
ABI5600). ESI was conducted by using a needle voltage of 4.0 kV in a negative ion
mode. A heated capillary was set at 600 ℃. The nebulizer gas pressure was 40 psi;
the heater gas pressure was 40 psi; the curtain gas pressure was 25 psi; the
declustering potential was -220 V; and the collision energy was -10 V.

Liquid

chromatographic separation was performed using a Phenomenex Luna C 18 column
(4.6 × 100 mm; 5 µm) at a flow rate 0.4 mL/min. Solvent A was 10 mM ammonium
acetate in water and solvent B was 100% acetonitrile. A solvent gradient was carried
out under the following conditions: 2.0% of B for 0.5 min, 2.0 to 17.4% of B over
11min, 17.4 to 60.0% of B over 0.1 min, 60.0% of B for 2 min, 60.0 to 2.0% of B over
0.1 min, and 2.0 % B over 3.3 min.
MS/MS Analysis. Oligonucleotide fragmentation analyses were performed by
manually injecting the oligonucleotide samples of 100 pmol/µl into AB Sciex triple
quadrupole-TOF mass spectrometers (ABI4600 and ABI5600). The syringe flow rate
was set at 10 µl/min. ESI was conducted by using a needle voltage of 4.5 kV in a
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negative ion mode. A heated capillary was set at 400 ℃. The nebulizer gas pressure
was 75 psi; the heater gas pressure was 25 psi; the curtain gas pressure was 25 psi; the
declustering potential was -100 V; and the collision energy was -15 V. The parent ion
m/z for m6A, m1A, m3C and m3U were selected as 816.14 (-6 charge), 816.14 (-6
charge), 974.77 (-5 charge) and 974.96 (-5 charge), respectively. Data analyses were
performed with the AB Sciex Analyst TF software 1.7.
Exonuclease Digestion

with

MALDI-TOF Analysis.

The modified

oligonucleotides were characterized by 3’-5’exonuclease digestion followed by
MALDI-TOF analysis. In general, 1.0 μL of sample containing 200-250 pmol of a
modified oligonucleotide was used for digestion. SVP (0.2 unit) was added together
with 6.0 μL of ammonium citrate (100 mM, pH 9.4) and 6.0 μL of water for the 3′ to
5′ digestion.11 For the MALDI-TOF analyses, 1.0 μL of the mixture was used at a
certain time point until the digestion was almost finished; the digestion was quenched
by mixing with 1.0 μL of MALDI analysis matrix (3-hydroxypicolinic acid and diammonium hydrogen citrate in a 1:1 ratio). Samples were analyzed by a Shimadzu
Axima Performance MALDI-TOF mass spectrometer using a 50Hz laser with a power
setting of 90 in positive ion reflection mode with 500 shots collected.13
Enzymatic Reaction with the AlkB protein and HPLC Analysis. All reactions
were performed at 37 ℃ for 1 h in a reaction buffer containing 70.0 μM
Fe(NH4)2(SO4)2·6H2O, 0.93 mM α-ketoglutarate, 1.86 mM ascorbic acid, and 46.5
mM HEPES (pH 8.0).10 The reactions were quenched by adding 10.0 mM EDTA
followed by heating at 95 ℃ for 5 min. Typically, 0.25 µM of the purified AlkB
protein was incubated with 5.0 µM m6A and m1A in the presence of all cofactors in a
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20 μL reaction volume. For the m3C and m3U, 0.18 µM of AlkB was incubated with
5.0 µM of oligonucleotides. Samples were then analyzed under an HPLC condition
that was able to separate the substrate and product.
To separate the starting material and product of the enzymatic reactions for the
four lesions, different HPLC conditions were optimized by using either C18 or anion
exchange columns. The UV detection was set at 260 nm. Specifically, (1) m6A and
its repaired product A were analyzed by using a Phenomenex Luna Semi-Preparative
C18 column (10 x 150 mm, 5 µm) under the following conditions: Solvent A was 100
mM triethylammonium acetate in water and solvent B was 100% acetonitrile. A
solvent gradient was carried out under the following conditions: 2.0% of B for 0.2 min,
2.0 to 9.0% of B over 0.3 min, 9.0 to 9.4% of B over 16 min, 9.4 to 70.0% of B over
0.5 min, 70.0% of B for 3 min, 70.0 to 2.0% of B over 0.5 min, and 2.0 % B for 4.5
min. The flow rate was at 3.0 ml/min. The column oven was set at 40 ℃. This
protocol was also used to analyze m3U and its repair product U. (2) m1A and its
repaired product A were analyzed by using a Thermo DNAPac PA-100 anion
exchange column (4 x 250 mm, 13 µm) with solvent A as water and solvent B as 1.5
M ammonium acetate in water.

A solvent gradient was carried out under the

following conditions: 50.0% of B for 1 min, 50.0 to 52.0% of B over 2 min, 52.0 to
75.0% over 1 min, 75.0% of B for 2 min, 75.0 to 50.0% of B over 0.5 min, and 50.0%
of B for 4.5 min. The flow rate was at 4.0 ml/min. (3) m3C and its repaired product C
were analyzed with a similar protocol to m1A/A analysis, except the solvent gradient
was changed to the following conditions: 50.0% of B for 1 min, 50.0 to 57.0% of B
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over 1 min, 57.0% of B for 2 min, 57.0 to 50.0% of B for 0.5 min, then 50.0% of B for
4.5 min.
RESULTS
Identification of m6A Byproduct from m1A Synthesis. We were trying to
incorporate m1A into an oligonucleotide as a substrate for the AlkB repair reaction.34,40
A 16mer oligonucleotide containing m1A was prepared by using the commercially
available phosphoramidite of m1A (Figure 1a). The final product was deprotected
under standard conditions by treating the crude oligonucleotide with ammonium
hydroxide at 80 ℃ for 3h. The oligonucleotide was then tested by both reverse phase
and anion exchange HPLC (see Experimental Procedures for detailed conditions).
The resulting chromatograms showed a single peak under both conditions (retention
time 10.2 min in Figure 2a and 4.0 min in Figure S22). High resolution ESI-TOF MS
analysis of the sample exhibited m/z at 1224.715 at its -4 charge state, which is in
good agreement with the theoretical m/z 1224.711 expected of the product
oligonucleotide (Figure 3a, S1 and Table 1).
Collision-induced-dissociation (CID) MS/MS analysis was used to determine the
location of the alkyl adduct in the synthesis of m1A-containing 16mer oligonucleotide
(Figure 4). The MS/MS results, presented in detail in the supporting information
(Figures S5 and Tables S1), confirmed that modification occurred at the eighth
position from the 3’ end of the oligonucleotide and the modified base had the same
MW as m1A. Analysis of 3’ end fragmentations indicated that w15 to w8 fragments all
contain an extra methyl modification (Figure 4, Table S1 and Figure S10). On the
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other hand, w7 to w1 ions showed only standard DNA sequences without methyl
modification (Table S1). These results suggested the modification is located between
w8 and w7, which is the eighth position from the 3’ end of the 16mer oligonucleotide.
From the 5’ fragmentations, we observed the methyl modification in ions from (a15-C)
to (a10-G), but no such modification from ion (a9-X) to (a2-A) (Figure 4, Figure S9 and
Table S1). These results suggested the modification is located between (a10-G) and
(a9-X), which is the ninth position from the 5’ end (Figure 4). The fragmentation
patterns from both the 5’ and 3’ ends are consistent with the proposed m1A-containing
DNA sequence (Figure 4).
To further confirm the location of the modified base, we performed enzymedigestion coupled with MALDI-TOF MS analysis.11–13,41,42 The procedure has been
widely used to confirm the location of lesion positions by determining the mass
changes after partial digestion from the 3’ end by the exonuclease SVP.43–45 Figure 5
shows the positive ion MALDI-TOF MS spectra of the 3’ to 5’ SVP exonuclease
digestion of the product oligonucleotide at different time intervals. The m/z of 4904.2
at 0 min (before digestion, as a control) indicated the 16mer DNA sequence contained
a methylated DNA base (theoretical m/z = 4902.9 Dalton, herein theoretical m/z values
are shown in parentheses after the observed m/z values).

After 1 minute SVP

digestion, while the product ion disappeared, three new lower masses appeared at m/z
= 4615.7 (4614.8), 4326.7 (4325.8), and 4022.7 (4021.7), which correspond to the 15,
14, and 13mer fragments generated from 3’ cleavage, respectively (Figure 5). The
signal intensity of three new peaks were significantly increased with the disappearance
of the original product oligonucleotide ion at m/z = 4904.2.
10

Further digestion resulted in a number of smaller fragments. In 3 min digestion
(Figure 5 and S17), the signal of m/z = 3075.1 (3074.6) matches the sequence for the
fragment that was cleaved one base before the lesion. The m/z = 2746.4 (2745.5,
containing a methyl modification), represents the digestion occurring on the 3' side of
the modified adenine position (Figure 5), which also persisted in the 5 min digestion
spectrum. The signal at 2419.1 (2418.5, no methyl modification) in the 3 and 5 min
digestions

represents

the

fragment

generated

after

liberation

of

the

deoxymethyladenosine 5' monophosphate. Digestions practically stopped at m/z =
1223.6/8 (1222.3), which represent the m/z of a 4mer nucleotide of the 5’ end. Taken
together, these results confirm that the modified structure is a methylated adenine and
it is at the ninth position of the proposed oligonucleotide from the 5’to 3’ direction.
The chromatographic and mass spectral evidence presented above indicates that
the product oligonucleotide could have the MW expected for a 16mer containing the
m1A adduct in the correct position. We then tested the repair of this product by the
AlkB protein, which is an enzyme that repairs various alkylated DNA adducts (Figure
1b).32,34 The result showed the repair efficiency of this oligonucleotide by AlkB was
very low, even when 2.5 uM of AlkB was incubated with 5.0 uM product
oligonucleotide (Figure 6b and Figure S24). This observation was in contrast to the
report that m1A is a good substrate of AlkB (eg. 0.2 µM of AlkB is able to repair 5.0
µM m1A completely in 1 h).10

We suspected that the structure in the product

oligonucleotide may not be m1A, even though it had an identical MW to m1A. The
reverse phase HPLC results also showed an anomalous phenomenon. For example,
the positively charged m1A nucleobase34 should be more polar than the natural base
11

adenine and thus have a shorter retention time on a C18 column. However, the
opposite was observed: adenine has ashorter retention time than the product (Figure 2a
and 2c). It has been reported that 6-methyladenine (m6A) could be generated from a
Dimroth rearrangement of m1A under basic conditions(Figure 1a and Table 1).34,46
We therefore conducted a new batch synthesis of m1A under a milder
deprotection condition (25 ℃ for 16 h). The product oligonucleotide was eluted as a
single peak in both HPLC columns (Figure 2b for C18 and Figure 6d for anion
exchange). The HPLC retention time in reverse phase HPLC exhibited a shorter
retention time (8.5 min, Figure 2b) than the non-modified control adenine (9.0 min,
Figure 2c) or the previous product (10.2 min, m6A, Figure 2a), in good agreement
with the theory that m1A should be more polar than both A and m6A.
The MW of the new product was characterized by HR-MS and had the correct
m/z of m1A at 1224.715 (1224.711) (Figure 3b, S2 and Table 1). The MS/MS results
(e.g., the w7, w8, a9-X, and a10-G ions, Figure 4, Figure S6, S11, S12, and Table S2)
demonstrated the modification is at the ninth position from the 5’ end and it is a
methylated adenine. The exonuclease digestion with MALDI-TOF analyses (Figure
S18 and S21a) also confirmed the location and identity of adduct. For example, the
2746.1 (before adduct) and 2418.8 (after adduct) peaks at 3 min digestion in Figure
S18 were present.

Finally, incubation with AlkB showed an excellent repair

efficiency against the new product oligonucleotide: 5.0 µM adduct was mostly
repaired in 1 hr with 0.2 µM enzyme (Figure 6e).10

Taken together, these results

confirmed the newly synthesized product as a 16mer oligonucleotide containing m1A
at the ninth position from the 5’ end (Figure 1a).
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Identification of m3U Byproduct from m3C Synthesis. We also wanted to
synthesize an oligonucleotide containing m3C as the substrate for the AlkB family
DNA repair reactions within the same sequence context as for the m1A
oligonucleotide (Figure 1a).34,40 After automated synthesis and standard deprotection
(80 ℃ for 3h), the HPLC chromatogram from a C18 column showed two peaks with
similar intensities (9.5 min and 11.6 min, Figure 2d), which were readily separated
(Figure 2e and 2f). HR-MS analysis showed that the early eluting peak (9.5 min,
Figure 2e) had an m/z value 1218.703 at -4 charge state (Figure 3c and S3), which is in
agreement with that of the m/z of the target m3C containing oligonucleotide
(theoretical m/z 1218.709, Table 1). The second species at 11.6 min (Figure 2f)
showed an m/z 1218.957 at its -4 charge state (Figure 3d and S4). Compared to the
9.5 min peak, the m/z value of the second species was 0.254 unit higher at the -4
charge state, indicating that the MW (4,879.850 Dalton) of the second species is 1.016
Dalton higher than the first one.

This is consistent with the m/z value of an

oligonucleotide containing m3U at its -4 charge state (1218.955, Table 1). m3U could
potentially be generated from deamination of m3C under basic conditions (Figure
1a).47 The MS/MS results of the two oligonucleotides (e.g., the w7, w8, a9-X, and a10G ions, Figure 4, Figure S7, S8, S13 to S16, Table S3, and S4) demonstrated the
modifications are at the ninth position from the 5’ end. The exonuclease digestion
with MALDI-TOF analyses (Figure S19, S20 and S21b) also confirmed the location
and identity of the adducts. At 7 minute digestion, signature peaks were 2722.2
(before adduct) and 2418.8 (after adduct) for m3C (Figure S18); and 2723.3 (before
adduct) and 2418.7 (after adduct) for m3U (Figure S19). The C18 HPLC retention
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time of the two species showed m3C containing oligonucleotide had a shorter
retention time (9.5 min, Figure 2e) than m3U (11.6 min, Figure 2f). This result
indicated m3C is more polar than m3U, which supports that m3C is positively charged
at pH 7.0 (Figure 1a).34 The AlkB reaction (0.2 µM) on the m3C oligonucleotide
showed a good repair efficiency: 5.0 µM m3C adduct was mostly repaired to cytosine
after 1 h (Figure 6h). This was not the case for m3U containing oligonucleotides
under a similar condition, which showed almost no repair to m3U (Figure 6k). These
observations were consistent with the observations that m3C is a strong substrate but
m3U is a weak substrate for AlkB under both in vitro and in vivo conditions.34,48
To avoid the formation of m3U, we carried out a second batch synthesis of m3C
containing oligonucleotide under a milder deprotection condition (25 ℃ for 16 h).
This time we observed only the m3C containing species in the HPLC chromatogram
(similar to Figure 2e). The identity of the newly synthesized m3C was confirmed by
the aforementioned spectroscopic and enzymatic tests. These results indicate that the
formation of the byproduct m3U was from deamination of m3C catalyzed by harsh
deprotection conditions (high temperature and alkaline).47,48

Serendipitously, the

formation of m3U in the first batch of synthesis provides a new method for chemically
preparing m3U-containing oligonucleotide.
DISCUSSION
For the synthesis of m1A, we observed a byproduct m6A, which exhibited
identical MW and location to m1A. It is difficult to differentiate m1A and m6A
without conducting bioassays and careful HPLC retention analysis. As for m3C, it
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was the m3U byproduct that showed a 1 Dalton difference in the ~ 4,900 Dalton
context (Table 1). The two oligonucleotides could be eluted as a single species in
HPLC under certain conditions, thus it is imperative to perform high resolution MS
analysis and enzymatic reaction to distinguish the two products. For HPLC analysis
of modified oligonucleotides, we used a combination of two different separation
systems, such as reverse phase (e.g. C18) and anion exchange chromatography. For
example, it is not easy to find a suitable condition for fully separating 16mer
containing m1A and A with C18 columns (Figure 2b and 2c). However, it is relatively
easy to separate them with an anion exchange column, since m1A is positively
charged at neutral pH but A is not (Figure 1a, 6d and 6f).34 On the other hand, it is not
easy to distinguish m6A and A under anion exchange condition (Figure S22 and S23)
because of their neutrality at pH 7.0, but it is possible to separate them on the C18
column (Figure 2a and 2c).
The MW of the oligonucleotide can be determined by HR-MS, and the location of
the modification can be identified by MS/MS or exonuclease digestion with MALDITOF analysis. To further confirm the identity of the oligonucleotide from a biological
activity perspective, we recommend running enzymatic reaction on the product. In
this work, we used SVP exonuclease to digest all oligonucleotides formed in the
syntheses. A specific enzyme for certain types of modification could greatly help
elucidate the structure of modification. So we tested the repair efficiency of m1A and
m3C and their byproducts by the AlkB repair enzyme.32,34 The AlkB protein in E. coli
is an α-ketoglutarate/Fe(II)-dependent dioxygenase that repairs various alkyl DNA
adducts, including m1A and m3C (Figure 1).30–32,40,49–51 We found that m1A and m3C
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are good substrates but m6A and m3U are weak substrates of AlkB.34,48,49 For other
modified structures, it is highly recommended that a biological or enzymatic assay
should be adopted for identifying the product. The reason for adopting an enzymatic
test is because a byproduct (e.g. m6A) may have an identical MW as the target product
(e.g. m1A), which may be hard to differentiate by LC and MS analyses, including the
MS/MS and exonuclease digestion with MALDI-TOF analysis.
CONCLUSION
Chemical synthesis of oligonucleotides is important for conducting various
biological, chemical,

and medical research

including oligonucleotide drug

development. The field of oligonucleotide synthesis has progressed such that DNA
and RNA containing standard bases can be ordered from commercial sources. Most of
these oligonucleotides are in high quality, but it is a good practice to perform quality
control in order to confirm the products have the correct sequences in high purity. A
simple HPLC/MS analysis should be sufficient for most applications. However, a
more rigorous and stringent quality control procedure52–54 should be adopted for sitespecifically modified oligonucleotides, such as epigenetic marks, DNA adducts, and
drug candidates.

In some cases, byproducts are generated from side chemical

reactions during standard automated synthesis and deprotection steps. For this reason,
specific deprotection conditions may be required for preparation of oligonucleotide
containing modifications, such as epigenetic biomarkers: 5-hydroxymethyl-dC, 5formyl-dC, and 5-carboxy-dC.55,56 After synthesis and deprotection, it is even more
important to carry out a thorough purification and characterization procedure to ensure
1) complete removal of protecting groups, 2) product having high purity, and 3)
16

modification having the correct position and identity. In this study, we used a reliable
and robust procedure to characterize byproducts from m1A and m3C syntheses. The
protocol used here could be helpful for identifying byproducts generated from other
oligonucleotide syntheses.
FIGURES

Figure 1. Oligonucleotide products and byproducts studied in this work.

a) the

structures of adducts and byproducts from chemical syntheses and b) the alkyl adduct
m1A, as an example, is repaired in the presence of the AlkB enzyme and necessary
cofactors.
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Figure 2. Reverse phase HPLC chromatograms of 16mer DNA alkyl products and
byproducts. The retention time of a modification-containing oligonucleotide is labeled
on top of the corresponding chromatogram. The modifications are: a) m6A); b) m1A;
c) A; d) mixture of m3C + m3U; e) m3C; and f) m3U.
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Figure 3. High resolution ESI-TOF MS analyses of 16mer DNA oligonucleotides
containing target modifications and byproducts.

Data represent the -4 charge

envelopes and the monoisotopic peak (all 12C, 14N, etc.) values are labeled above the
first peak in each peak envelope. a) The oligonucleotide (containing m6A) generated
from initial m1A synthesis; b) m1A; c) m3C; and d) m3U.
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Figure 4. Predicted fragmentation pattern from collision-induced-dissociation of the
16mer oligonucleotide products from the m1A and m3C syntheses. X denotes the
modified nucleotides.

Figure 5. Time-course MALDI-TOF analyses of SVP digestion products of the
16mer product oligonucleotide (containing m6A) generated from m1A synthesis.
Theoretical masses are listed in the inset. The theoretical monoisotopic mass at
2745.5 is highlighted in red because it is the smallest digestion product containing the
modification.
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Figure 6. HPLC profiles of the AlkB repair reactions on different alkyl substrates.
The three chromatograms within each panel represent one set of repair reaction
including the oligonucleotides of starting material, reaction mixture, and product. For
example, in the panel containing chromatograms a, b, & c, a) represents the starting
material m6A, b) represents the repair reaction of m6A by AlkB, and c) represents the
pure product adenine synthesized separately. Chromatograms shown in a, b, & c
relevant to m6A repair and in j, k, & l relevant to m3U repair were analyzed under
reverse phase conditions. Chromatograms shown in d, e, & f relevant to m1A repair
and in g, h, & i relevant to m3C repair were analyzed under anion exchange conditions
(see Experimental Procedures for detailed information). a) m6A; b) m6A+AlkB; c) A;
d) m1A; e) m1A+AlkB; f) A; g) m3C; h) m3C+AlkB; i) C; j) m3U; k) m3U+AlkB;
and l) U.
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Figure S1. ESI-TOF analysis of 16mer oligonucleotide containing m6A at -4 charge
state.

Figure S2. ESI-TOF analysis of 16mer oligonucleotide containing m1A at -4 charge
state.
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Figure S3. ESI-TOF analysis of 16mer oligonucleotide containing m3C at -4 charge
state.

Figure S4. ESI-TOF analysis of 16mer oligonucleotide containing m3U at -4 charge
state.

23

Figure S5. MS/MS fragmentation analysis of 16mer containing m6A. The diamond
marks the parent ion.

Figure S6. MS/MS fragmentation analysis of 16mer containing m1A. The diamond
marks the parent ion.
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Figure S7. MS/MS fragmentation analysis of 16mer containing m3C. The diamond
marks the parent ion.

Figure S8. MS/MS fragmentation analysis of 16mer containing m3U. The diamond
marks the parent ion.
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Figure S9. MS/MS fragmentation spectrum of 16mer containing m6A. The peak
envelope indicates the a10-G ion at -3 charge state.

Figure S10. MS/MS fragmentation spectrum of 16mer containing m6A. The peak
envelope indicates the W8 ion at -4 charge state.
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Figure S11. MS/MS fragmentation spectrum of 16mer containing m1A. The peak
envelope indicates the a10-G ion at -3 charge state.

Figure S12. MS/MS fragmentation spectrum of 16mer containing m1A. The peak
envelope indicates the W8 ion at -4 charge state.
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Figure S13. MS/MS fragmentation spectrum of 16mer containing m3C. The peak
envelope indicates the a10-G ion at -3 charge state.

Figure S14. MS/MS fragmentation spectrum of 16mer containing m3C. The peak
envelope indicates the W8 ion at -3 charge state.

28

Figure S15. MS/MS fragmentation spectrum of 16mer containing m3U. The peak
envelope indicates the a10-G ion at -3 charge state.

Figure S16. MS/MS fragmentation spectrum of 16mer containing m3U. The peak
envelope indicates the W8 ion at -3 charge state.
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Figure S17. MALDI-TOF analyses on the exonuclease digestion of 16mer containing
m6A.

Figure S18. MALDI-TOF analyses on the exonuclease digestion of 16mer containing
m1A.

Figure S19. MALDI-TOF analyses on the exonuclease digestion of 16mer containing
m3C.
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Figure S20. MALDI-TOF analyses on the exonuclease digestion of 16mer containing
m3U.

Figure S21. Detailed MALDI-TOF spectra of oligonucleotides in the exonuclease
digestion assays. a) m1A and b) m3C.
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Figure S22. HPLC analysis of 16mer m6A oligonucleotide under anion exchange
condition. The retention time is about 4.0 min.

Figure S23. HPLC analysis of 16mer A oligonucleotide under anion exchange
condition. The retention time is about 4.0 min.
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Figure S24. MS spectra of the AlkB protein repairs 16mer m6A oligonucleotide at -4
charge state. Top: 5.0 µM of m6A without addition of AlkB (peak envelope starts at
33

m/z 1224.7).

Bottom: 5.0 µM of m6A with addition of 2.5 µM AlkB and

corresponding cofactors. A very small amount of m6A (peak envelope starts at m/z
1224.7) was repaired to A (peak envelope starts at m/z 1221.2).
TABLES

Table 1. Calculated and observed monoisotopic molecular weight and m/z value of
modified oligonucleotides. For m1A and m3C synthesis, the sequence of the 16mer
was 5’-GAAGACCTXGGCGTCC-3’, where X indicates the position of the modified
bases.

MW
(calculated)

m/z (calculated)

m/z (observed)

of neutral

-4 charge peak

-4 charge peak

Lesion or base

species
16mer m6A

4902.877

1224.711

1224.715

16mer m1A

4902.877

1224.711

1224.715

16mer m3C

4878.866

1218.709

1218.703

16mer m3U

4879.850

1218.955

1218.957
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Table S1. Observed and predicted m/z for high resolution MS/MS fragmentation
patterns displayed in Figure S5 of 16mer containing m6A. Predicted CID fragments
are shown in Figure 4.
Fragment
W1
W2
W3
W4
W5
W6
W7
W8
W9
W10
W11
W12
W13
W14
W15
a2-A
a3-A
a4-G
a5-A
a6-C
a7-C
a9-X
a10-G
a11-G
a12-C
a13-G

Charge
-1
-2
-2
-2
-2
-3
-3
-3
-3
-3
-4
-4
-4
-5
-5
-1
-2
-2
-2
-2
-3
-3
-3
-3
-4
-4

Theoretical m/z
306.049
297.044
449.067
613.593
758.116
614.759
724.443
833.468
934.816
1031.165
845.384
923.648
1005.911
867.139
929.750
426.081
369.066
525.594
690.121
846.650
660.446
858.143
967.168
1076.852
889.650
961.912
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Observed m/z
306.045
297.043
449.066
613.593
758.118
614.753
724.441
833.467
934.816
1031.170
845.379
923.645
1005.913
867.131
929.751
426.079
369.064
525.596
690.119
846.649
660.446
858.145
967.167
1076.851
889.650
961.911

Table S2. Observed and predicted m/z for high resolution MS/MS fragmentation
patterns displayed in Figure S6 of 16mer containing m1A. Predicted CID fragments
are shown in Figure 4.
Fragment
W1
W2
W3
W4
W5
W6
W7
W8
W9
W10
W11
W12
W13
W14
W15
a2-A
a3-A
a4-G
a5-A
a6-C
a7-C
a8-T
a9-X
a10-G
a11-G
a12-C
a13-G

Charge
-1
-2
-2
-2
-2
-3
-3
-3
-3
-3
-4
-4
-4
-5
-5
-1
-2
-2
-2
-2
-2
-2
-3
-3
-3
-4
-4

Theoretical m/z
306.049
297.044
449.067
613.593
758.116
614.759
724.443
833.468
934.816
1031.165
845.384
923.648
1005.911
867.139
929.750
426.081
369.066
525.594
690.121
846.650
991.173
1135.696
858.143
967.168
1076.852
889.650
961.912
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Observed m/z
306.047
297.041
449.065
613.592
758.115
614.759
724.442
833.467
934.815
1031.162
845.383
923.645
1005.909
867.134
929.750
426.078
369.063
525.594
690.120
846.646
991.174
1135.701
858.148
967.167
1076.850
889.647
961.907

Table S3. Observed and predicted m/z for high resolution MS/MS fragmentation
patterns displayed in Figure S7 of 16mer containing m3C. Predicted CID fragments
are shown in Figure 4.
Fragment
W1
W2
W3
W4
W5
W6
W7
W8
W9
W10
W11
W12
W13
W14
W15
a2-A
a3-A
a4-G
a5-A
a6-C
a7-C
a8-T
a9-X
a10-G
a11-G
a12-C
a13-G

Charge
-1
-1
-2
-2
-2
-2
-3
-3
-3
-4
-4
-4
-4
-4
-4
-1
-1
-2
-2
-2
-2
-2
-3
-3
-3
-4
-4

Theoretical m/z
306.049
595.095
449.067
613.593
758.116
922.643
724.443
825.464
926.813
767.119
839.381
917.645
999.908
1078.173
1156.437
426.081
739.139
525.594
690.121
846.650
991.173
1135.696
858.143
959.164
1068.848
883.647
955.909
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Observed m/z
306.049
595.095
449.065
613.593
758.118
922.644
724.444
825.464
926.816
767.117
839.380
917.647
999.911
1078.170
1156.437
426.081
739.140
525.593
690.121
846.652
991.177
1135.701
858.144
959.162
1068.851
883.650
955.907

Table S4. Observed and predicted m/z for high resolution MS/MS fragmentation
patterns displayed in Figure S8 of 16mer containing m3U. Predicted CID fragments
are shown in Figure 4.

Fragment
W1
W2
W3
W4
W5
W6
W7
W8
W9
W10
W11
W12
W13
W14
W15
a2-A
a3-A
a4-G
a5-A
a6-C
a7-C
a8-T
a9-X
a10-G
a11-G
a12-C
a13-G

Charge
-1
-1
-2
-2
-2
-3
-3
-3
-3
-4
-4
-4
-4
-4
-5
-1
-1
-2
-2
-2
-2
-2
-2
-3
-3
-4
-4

Theoretical m/z
306.049
595.095
449.067
613.593
758.116
614.759
724.443
825.792
927.141
767.365
839.627
917.891
1000.154
1078.419
925.145
426.081
739.139
525.594
690.121
846.650
991.173
1135.696
1287.719
959.492
1069.176
883.893
956.155
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Observed m/z
306.047
595.092
449.066
613.593
758.114
614.758
724.444
825.791
927.141
767.362
839.627
917.887
1000.154
1078.414
925.139
426.079
739.137
525.593
690.118
846.648
991.172
1135.692
1287.711
959.496
1069.173
883.889
956.152
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CHAPTER 2

ADAPTIVE RESPONSE ENZYME ALKB PREFERENTIALLY REPAIRS
1‑METHYLGUANINE AND 3‑METHYLTHYMINE ADDUCTS IN DOUBLESTRANDED DNA
[PUBLISHED ON CHEMICAL RESEARCH IN TOXICOLOGY 2016, 29, 687-693]
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ABSTRACT
The AlkB protein is a repair enzyme that uses an α-ketoglutarate/Fe(II)-dependent
mechanism to repair alkyl DNA adducts. AlkB has been reported to repair highly
susceptible substrates, such as 1-methyladenine and 3-methylcytosine, more
efficiently in ss-DNA than in ds-DNA. Here, we tested the repair of weaker AlkB
substrates 1-methylguanine and 3-methylthymine, and found that AlkB prefers to
repair them in ds-DNA. We also discovered AlkB and its human homologs, ABH2
and ABH3, are able to repair the aforementioned adducts when the adduct is present in
a mismatched base pair. These observations demonstrate the strong adaptability of
AlkB on repairing various adducts in different environments.
INTRODUCTION
Nuclear DNA is constantly exposed to damage from exogenous and endogenous
processes, generating a variety of DNA adducts in the genome.1–3 If those adducts
occur in a single stranded (ss) DNA region, such as at a replication fork, they may
cause mutations or replication blocks during DNA synthesis. If the lesions occur in a
double stranded (ds) context, they may additionally change local DNA architecture,
leading to an unstable DNA duplex, or possibly disrupt the proper recognition of
specific sites by sequence-specific DNA binding proteins, such as transcription
factors.1,2

To avoid these adverse effects from DNA adducts, organisms have

developed an array of DNA repair pathways that are able to protect cells against
lesions in both ss- and ds-DNA. One of these enzymes, the adaptive response protein
AlkB of E. coli, has been reported to repair alkyl DNA adducts, such as 1-
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methyladenine (m1A) and 3-methylcytosine (m3C), in both ss- and ds-contexts,
although it prefers repairing lesions in single stranded substrates.4–9
The AlkB protein was discovered to be a dioxygenase that uses an αketoglutarate/Fe(II)-dependent mechanism to oxidize the aberrant alkyl groups,
ultimately restoring the undamaged DNA bases (Figure 1a).4,5 Different homologs of
the E. coli AlkB protein exist in prokaryotic and eukaryotic species; nine such
homologs exist in human cells (ABH1-8 and FTO).4,5

Among the nine AlkB

homologs, ABH1 functions as an apyrimidinic/apurinic lyase and nucleic acid
demethylase.6,7 ABH48,9 and ABH710,11 modify protein substrates and ABH812–16 is a
tRNA methyltransferase and hydroxylase.

ABH517–21 and FTO22–25 have been

demonstrated to work on N6-methyladenine (m6A) in RNA or DNA. ABH22,26–30 and
ABH331–34 are DNA repair enzymes; and the function of ABH6 remains to be
established. Since the discovery of this class of enzymes, a variety of DNA adducts
have been identified as substrates for AlkB and its mammalian homologs, ABH2 and
ABH3, both in vitro and in vivo.1,10–13 The adducts include all of the seven N-methyl
lesions occurring at the Watson-Crick (W-C) base-pairing face of the four
nucleobases.13

The seven adducts include m1A, m3C, m6A, N4-methylcytosine

(m4C), 1-methylguanine (m1G), N2-methylguanine (m2G), and 3-methylthymine
(m3T). Among these lesions, m6A, m4C and m2G are exocyclic adducts whose
structures afford the opportunity to avoid disruption of W-C base-pairing by allowing
the methyl group to swivel away from the H-bond interface.

By contrast,

m1A/m3C/m1G/m3T have the methyl group on the nucleobase ring, which
unavoidably will interfere with hydrogen-bond pairing if left unrepaired. AlkB has
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also been reported to repair other DNA adducts, such as 3-ethylcytosine (e3C), N2ethylguanine,

1,N6-ethenoadenine

(εA),

3,N4-ethenocytosine

(εC),

1,N2-

ethenoguanine (1,N2-εG), 1,N6-ethanoadenine (EA), 3,N4-α-hydroxyethanocytosine
(HEC), 3,N4-α-hydroxypropanocytosine (HPC), N2-furan-2-yl-methylguanine, N2α-hydroxypropanoguanine,

tetrahydrofuran-2-yl-methylguanine,

γ-

hydroxypropanoguanine, and malondialdehydeguanine.35–43 The substrate scope and
repair efficiency of the AlkB family enzymes have been reviewed by several
papers.1,5,44,45
EXPERIMENTAL PROCEDURES
Oligonucleotide synthesis.

Sixteen-mer oligonucleotides (oligos) with the

sequence 5’-GAAGACCTXGGCGTCC-3’ containing the lesions at X position were
made by using solid-phase phosphoramidite chemistry36,37,40–42 on a MerMade-4
Oligonucleotide Synthesizer. The complementary 17mer oligos were synthesized with
the sequence of 5’-TGGACGCCYAGGTCTTC-3’, where Y represents the position
incorporating the regular bases A, C, G and T. For the ss-23mer unrelated DNA, the
sequence was 5’-AAAGCTTCTGCAATCAGGTTCAG-3’. The oligos were purified
by reverse-phase HPLC with two solvents. Solvent A was 100 mM 1:1 triethylamineacetic acid (TEAA) in water and solvent B was 100% acetonitrile. The column was
Phenomenex DNAPac PA-100 Semi-Preparative (9 x 250 mm, 5µm). The
concentration of DNA was determined by UV absorbance at 260nm. The extinction
coefficient (ε) of a certain adduct is calculated as its unmodified counterpart due to the
negligible variation between the values in the context of a 16-mer DNA. The oligos
were characterized by HPLC-electrospray ionization (ESI) triple quadrupole-TOF
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mass spectrometry (MS) (AB Sciex). Solvent A was 10mM ammonium acetate in
water and solvent B was 100% acetonitrile. The column was Phenomenex Luna C 18
column (4.6 × 100 mm; 5µm). The calculated and observed monoisotopic MW and
m/z value of the oligos are shown in Table S1.
Expression and purification of the AlkB, ABH2 and ABH3 proteins. The
AlkB gene was cloned into a pET28a+ vector (EMD Millipore) and then transformed
into E. coli Rosetta2(DE3)pLysS (EMD Millipore) cells for expression.40,41

The

expressed protein was purified by affinity column chromatography, HisTrap HP (GE
Healthcare Life Sciences). Thrombin (Sigma-Aldrich, 0.005U/10μg protein) was used
to digest His-tag containing AlkB protein overnight.

Cation-exchange column

chromatography, HiTrap SP HP (GE Healthcare Life Sciences) was used for further
purification.

The final purified protein was concentrated by Amicon® Ultra

Centrifugal Filters (EMD Millipore) and stored in the AlkB storage buffer (10 mM
Tris, 100 mM NaCl, 1 mM 2-mercaptoethanol, 10% glycerol, pH 8.0). The ABH2
and ABH3 proteins were purified using the same procedure, with the exception that
the E. coli cell used for expression was BL21(DE3)pLysS (EMD Millipore) instead of
Rosetta2(DE3)pLysS. The ABH2 and ABH3 proteins were stored in the ABH storage
buffer (50 mM N-[Tris(hydroxymethyl)methyl]-3-aminopropanesulfonic acid, 300
mM NaCl, 10% glycerol, and 1 mM 2-mercaptoethanol, pH 8.0). Protein standard
was purchased from Bio-Rad.
Enzymatic reaction. All reactions were performed at 37 ℃ for 1h in a reaction
buffer containing 70 μM Fe(NH4)2(SO4)2·6H2O, 0.93 mM α-ketoglutarate, 1.86 mM
ascorbic acid, and 46.5 mM HEPES (pH 8.0).37,39,40 The reactions were quenched by
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adding 10 mM EDTA followed by heating at 95 ℃ for 5 min. Samples were then
analyzed by HPLC or HPLC-electrospray ionization triple quadrupole-TOF MS (AB
Sciex). Typically, the purified AlkB, ABH2 and ABH3 proteins were incubated with 5
µM DNA oligos in the presence of all cofactors in a 20 μL reaction volume. The
amount for these enzymes were variable on different substrates as shown in Table S35. For the double-stranded DNA substrates, 1.5 equivalents (7.5 μM) of the 17mer
complementary oligo containing A/C/G/T opposite to the adduct was annealed by
heating the mixture at 80 ℃ for 10 min and then cooled down slowly to room
temperature; the rest of the reaction was under similar conditions to ss-DNA repair
reaction. For the initial velocity measurements, the reactions were stopped at 0, 0.5, 1,
4, and 10min for m1A and m3C and at 0, 4, 8, and 12 min for m1G and m3T. For the
reactions with excessive amount of unrelated DNA, each reaction was carried out with
5μM substrate and additional 15μM ss-23mer DNA.

The corresponding

concentrations of the enzymes were listed in Table S5. Each reaction was carried out
in triplicate.
LC-MS analyses. Oligonucleotide analyses were performed on AB Sciex triple
quadrupole-TOF mass spectrometer. ESI was conducted using a needle voltage on 4.0
kV. Nitrogen gas was used with a setting of drying 40 L/min and a heated capillary at
600 ℃. Liquid chromatographic separation was performed using a Phenomenex Luna
C 18 column (4.6 × 100 mm; 5µm) at a flow rate 0.4 mL/min. Solvent A was 10mM
ammonium acetate in water and solvent B was 100% acetonitrile.40,41

A linear

gradient was carried out under the following conditions: 2.0% of B for 0.5 min, 2.0 to
17.4% of B over 11 min, 17.4 to 60.0% of B over 0.1 min, 60.0% of B for 2 min, 60.0
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to 2.0% of B over 0.1 min, then 2.0 % B over 3.3 min. The LC analyses were carried
out with the temperature of the column oven set at 40 ℃. Data analyses were
performed with the AB Sciex Analyst TF software 1.7. The relative amount of the
starting material and product was quantified by integrating the peak areas of the
corresponding oligos in the mass spectrum. In each reaction, we treated 16mer oligo
containing the starting material had the same ionization efficiency as the 16mer
product due to the negligible variation between the structures in the context of a 16mer DNA.
Statistical analyses. All statistical analyses were carried out by IBM SPSS
Statistics 23 and Microsoft Excel 2013. Statistical significance for data between two
groups were performed with Student’s two-tailed t test. P-value <0.05 was considered
as statistically significant.
RESULTS
AlkB has been reported to repair strong substrates, such as m1A and m3C, more
efficiently in ss-DNA than in ds-DNA.4–9 However, the strand preference of AlkB for
some of its weak substrates, such as m1G and m3T, remained unanswered. In this
work, we selected four lesions to investigate the repair efficiency of AlkB in both ssand ds-DNA (Figure 1b). Because these adducts are mutagenic to varying degrees,
causing misincorporation of non-authentic pairing bases during replication, we also
tested the ds-DNA conditions with all four DNA bases opposite to each adduct in the
complementary strand to demonstrate AlkB’s repair capacity under mismatch
conditions.

ABH2 and ABH3 have been reported to prefer repairing DNA adducts in

ds- and ss-DNA, respectively, and were also tested on those lesions.
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The ability of AlkB family enzymes to repair the four methylated bases was
tested in vitro using a previously reported experimental procedure.12,13 AlkB and its
human homologs were purified from E. coli cells (Figure S3-5). Oligos containing the
four adducts were synthesized by incorporating each adduct into a 16mer oligo in a
site-specific manner and their purity and identity were characterized by LC-MS
(Figure S6 and S8-11).11 For each lesion, experiments were conducted both in the
presence and absence of the repair enzyme with all necessary cofactors, and the
reaction products were analyzed by high resolution triple quadrupole-TOF MS (Figure
2). To test repair efficiency in ds-DNA, each adduct was first annealed to 17mer
complementary oligos (Figure S7 and S12-15) with all four DNA bases opposite the
lesion. To avoid the interference of the complementary oligo with the 16mer starting
material in the MS spectra, a 17mer complementary oligo was chosen because it has
~300 Daltons difference in MW than the 16mer oligo. The 16mer lesion-bearing
oligos demonstrated a good signal in the -4 charge envelope of the MS spectra (Figure
2). To illustrate the MS analysis, the MW of the 16mer containing an m1G lesion is
calculated as 4918.87 Daltons (Table S1); its monoisotopic peak (all 12C, 14N, 16O,
etc.) in the -4 charge state has a calculated mass/charge (m/z) of 1228.71.
Experimentally, we observed a peak at an m/z of 1228.70 (Figure 2c). The area
underneath the peak envelopes of the starting material and product were used to
quantify the conversion of the reaction (Figure 2).
For each lesion-containing oligo, 5µM starting material was used in the repair
reaction.

To accurately compare the efficiency of repair for each lesion, the

concentration of each enzyme was optimized to ensure no reaction proceeded to 100%
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conversion (Table S3). Acting upon an m1A lesion in ss-DNA, AlkB converted 53%
of the starting material to a 16mer product containing A at the lesion site (Figure 2a
and 3a). When m1A was annealed to the 17mer oligo containing complementary base
T, the theoretical perfect match in a repaired state, only 22% of m1A was repaired.
For m1A paired with mismatched bases, such as A/G/C, the reactions also showed
lower repair ratios than in ss-DNA (Figure 3a and Table S2). Similarly, AlkB was
demonstrated to repair m3C better in ss-DNA than ds-DNA with the exception that
m3C:A mismatched pair provided a slightly higher repair efficiency (Figure 3b and
Table S2). These results were consistent with the previous observations of AlkB’s
repair of m1A and m3C in ss- and ds-DNA.4–9
After testing the strong substrates of AlkB (m1A and m3C), the two weak
substrates m1G and m3T were investigated.

For m1G, 48% of the adduct was

repaired in ss-DNA, but 69% was repaired when m1G was put opposite to C (Figure
2c, 2d, 3c, and Table S2). For the mismatch reactions, complementary base A (50%)
and T (56%) also showed higher repair ratios than the single-stranded reaction. For
m3T repair, the ss-DNA condition (12%) provided the least efficient repair among all
conditions (Table S2). The perfect match of m3T with A was repaired 21% and the
mismatch with C yielded 28% conversion. Because m1A and m3C are the strong
substrates of the three enzymes and m1G and m3T are the weak substrates of the
proteins, the concentrations of the enzymes for different reactions varied significantly
from 0.08-5.0 μM in the steady state studies (Table S3). The concentrations were
optimized to make sure that the repair ratios were significantly different between ssand ds-repair. The results from m1G and m3T reactions demonstrated AlkB repairs
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them more efficiently in ds-perfect match conditions than in ss-DNA in the steady
state studies. To further support this conclusion, we also measured the initial velocity
of the repair reactions on the adducts in ss-DNA and in the perfect match ds-DNA
(Table 1). The results confirmed the preferential repair of m1G and m3T in ds-DNA,
and the differences of repair efficiency between ss- and ds-conditions were statistically
significant. On the other hand, the initial rates of repair on m1A and m3C were higher
in ss-DNA than ds-DNA (Table 1).
The current studies on AlkB’s repair of the four DNA adducts were carried out in
a 16mer sequence context, which is different from the situation in cell where adducts
are more likely to be present in parts per thousand or less. To study the repair of AlkB
with an excessive amount of non-damaged DNA, the repair reactions were performed
by adding of an extra 15 μM unrelated ss-23mer DNA oligos. This condition allowed
us to decrease the lesion:normal base ratio from 1:15 to 1:84. The repair efficiency
also supported the previous conclusions that AlkB prefers to repair m1G and m3T in
ds-DNA and m1A and m3C in ss-DNA with the repair ratio differences statistically
significant (Figure S16 and Table S5).
We also tested the repair of these four adducts by AlkB’s human homologs ABH2
and ABH3. For the repair ratios of the four lesions with ABH2, the double stranded
condition for the perfect match base pairs and most of the mismatch base pairs were
better repaired than ss-DNA, except the m3C:T mismatched pair (54%), which
demonstrated a slightly lower repair efficiency than m3C in ss-DNA (60%, Figure S1
and Table S2). For the repair of m1A and m3C by ABH3, ss-DNA repair was
consistently more effective than in ds-DNA (Figure S2 and Table S2). However, we
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were not able to detect the reaction products of m1G and m3T because they showed
very little repair susceptibility, even when ABH3 was present at a very high
concentration (5 µM, Table S3).

These results were consistent with previous

observations that ABH2 prefers ds repair and ABH3 prefers ss repair.28,29,46–50
DISCUSSION
In the above section, we demonstrated that AlkB is able to repair DNA adducts in
both ss- and ds-DNA. AlkB repairs m1A and m3C better in ss-DNA than in ds-DNA
for most strand conditions. However, the preference of repairing m1G and m3T is the
opposite: AlkB prefers to repair these lesions in perfect match and most of the
mismatch ds-DNA. AlkB has been reported to repair those four DNA adducts both in
vitro and in vivo.36,39

It has been demonstrated that m1A and m3C are strong

substrates for AlkB because both are positively charged under physiological pH
conditions.35,36 In AlkB deficient cells, m1A and m3C behave as strong replication
blocks: only ~12% of them could be bypassed by the replication polymerase. 36 m1A
is not mutagenic and m3C is ~ 30% mutagenic with the predominant mutations being
C to T and C to A. The existence of AlkB could completely repair m1A and m3C in
cell, thus fully alleviating their toxicity and mutagenicity. AlkB can also efficiently
repair e3C, εA and EA both in vitro and in vivo.36–38,40 On the other hand, m1G, m3T,
1,N2-εG and εC are weak substrates for AlkB with substantial cytotoxic and
mutagenic signatures in both AlkB positive and negative cells.36,37,43 For example,
m1G and m3T are only bypassed less than 10% of the replications in the absence of
the AlkB protein. The presence of AlkB only slightly increases the bypass of these
two adducts. For mutagenicity, m1G is ~80% mutagenic with G to T, G to A and G to
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C mutations without the repair of AlkB. Similarly, m3T is ~60% mutagenic with T to
A and T to C mutations. The mutagenicity of m1G and m3T decreases with the
presence of AlkB. The cellular results of AlkB’s repair on those four adducts support
the current observation that m1A and m3C are strong substrates of AlkB, and m1G
and m3T are weak substrates. If these two weak substrates are left unrepaired in cell,
they will not only strongly block replication but also cause a significant increment in
the percentage and type of mutations. Based on these observations, we hypothesize
that AlkB could efficiently repair strong substrates, such as m1A and m3C, in ss-DNA
before they encounter a polymerase. In contrast, AlkB cannot efficiently repair weak
substrates, such as m1G and m3T, when they exist in ss-DNA. AlkB may have
evolved to repair the weak substrates better in a ds-DNA context.

This preference

would avoid mutations to a certain degree, or in combination with mismatch repair,
could potentially prevent mutations pre- and post-replication.
Previously, Zhu et al. identified an active site region and key amino acid residues
that are responsible for the repair of m1A by AlkB and the repair of m6A by FTO and
ABH5.51

By swapping the active site sequences between the two types of

demethylases, they found the enhanced activity of not only AlkB on repairing m6A
but also FTO and ABH5 on m1A. Similarly, Chen et al. achieved preferential ssrepair by ABH2 and ds-repair by ABH3 (the opposite strand preference for both of the
enzymes) by swapping the recognition residues in their structures.27 AlkB has been
reported to repair different DNA adducts in both ss- and ds-DNA. Further structural
analysis should provide valuable information on AlkB’s strand preference of
m1A/m3C and m1G/m3T. Besides the strand preference, we also demonstrated that
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all three enzymes can repair lesions in ds-DNA under mismatch conditions; some of
the mismatches are even better repaired than the perfect match. These observations
demonstrate the strong adaptability of AlkB on repairing various adducts under
different strand and sequence contexts. The current studies utilized pH 8.0 and an iron
concentration that would provide a steady state measurement. However, Maciejewska
et. al have shown that AlkB’s repair efficiency depends on the pKa of substrates as
well as optimal Fe(II) ion concentration.35 They demonstrated the optimal repair of
m3C and HPC was achieved at pH 7.5, and the optimal repair of HEC was achieved at
pH 5.8. Correspondingly, the adducts would be positively charged under the above
pH conditions. The preference to positively charged adducts is possibly due to the
interaction with the negatively charged aspartate residue (Asp135) in the catalytic
center of AlkB. On the other hand, the poor repair efficiency on m1G and m3T could
be explained, at least partially, that the methylated nitrogen atoms in those two adducts
do not exist in cationic form under any pH condition (not limited to physiologically
relevant pH range).35,42

The molecular and structural mechanisms of AlkB’s

preference on ss- or ds-DNA warrant further investigation.
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FIGURES

Figure 1. a) Repair mechanism of the AlkB family enzymes on alkyl DNA lesions.
Adducts m1A and m1G are used here as examples to represent strong and weak
substrates of AlkB, respectively. b) The four DNA adducts studied in this work and
their strand preference (ss- vs ds-DNA) for AlkB to act on them.
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Figure 2. High resolution triple quadrupole -TOF MS analyses of AlkB repairing
different alkyl adducts in ss- and ds-DNA. Data represent the starting material and
product in their -4 charge envelopes, with the observed m/z values of their
monoisotopic (all 12C, 14N, 16O, etc.) peaks labeled above each envelope. The
percentage of the starting material and product in each reaction is also labeled above
the corresponding peak envelopes. The peak near m/z 1228.20 in panel c and d is
from a non-DNA impurity. a) AlkB + ss-m1A; b) AlkB + ds-m1A:T; c) AlkB + ssm1G; and d) AlkB + ds-m1G:C.
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Figure 3. Repair efficiency of AlkB on different 16mer adducts in ss- and ds-DNA.
For each lesion, the extent of repair in ss-DNA is colored in red, the extent of repair in
ds-DNA with non-mutagenic pairing is colored in yellow, and the extent of repair in
ds-DNA with mismatch bases is colored in green. Detailed information of enzyme
concentrations is listed in Table S3. The error bars represent the standard deviation
from triplicate experiments. The significance of the difference between ss-DNA and
ds-DNA with non-mutagenic pairing was tested using the Student’s two-tailed t test.
** indicates p-value <0.01. a) m1A; b) m3C; c) m1G; and d) m3T.
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Figure S1. Repair efficiency of ABH2 on different adducts in ss- and ds-DNA. The
error bars represent the standard deviation from triplicate experiments.

The

significance of the difference between ss-DNA and ds-DNA with non-mutagenic
pairing was tested using the Student’s two-tailed t test. ** indicates p-value <0.01.
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**

**

Figure S2. Repair efficiency of ABH3 on different adducts in ss- and ds-DNA. The
error bars represent the standard deviation from triplicate experiments.

The

significance of the difference between ss-DNA and ds-DNA with non-mutagenic
pairing was tested using the Student’s two-tailed t test. ** indicates p-value <0.01.
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Figure S3. Polyacrylamide gel electrophoresis of purified AlkB protein.
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Figure S4. Polyacrylamide gel electrophoresis of purified ABH2 protein.
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Figure S5. Polyacrylamide gel electrophoresis of purified ABH3 protein.
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Figure S6. Purity test of oligonucleotides containing the four alkyl adducts by HPLC.
The retention time of the oligos is around 5.0 min. For each test, 100pmol oligo was
injected. From top to bottom, the sub-figures represent 16mer oligos containing m1A,
m3C, m1G, and m3T.
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Figure S7. Purity test of oligonucleotides containing A/C/G/T in the 17mer
complementary strands by HPLC. The retention time of the oligo is around 5.0 min.
For each test, 100pmol oligo was injected. From top to bottom, the sub-figures
represent 17mer oligos containing A, C, G, and T.
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Figure S8. ESI-TOF analysis of 16mer oligonucleotide containing m1A.

Figure S9. ESI-TOF analysis of 16mer oligonucleotide containing m3C.
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Figure S10. ESI-TOF analysis of 16mer oligonucleotide containing m1G. The peak
at 1228.179 is from an impurity. The peak at 1228.704 is the monoisotopic peak of
the 16mer containing m1G.

Figure S11. ESI-TOF analysis of 16mer oligonucleotide containing m3T.
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Figure S12. ESI-TOF analysis of 17mer oligonucleotide containing A.

Figure S13. ESI-TOF analysis of 17mer oligonucleotide containing C.
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Figure S14. ESI-TOF analysis of 17mer oligonucleotide containing G.

Figure S15. ESI-TOF analysis of 17mer oligonucleotide containing T.
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Figure S16. Repair efficiency of AlkB on different adducts in ss- and perfect match
ds-DNA with non-mutagenic pairing and additional 15μM unrelated ss-23mer DNA.
The error bars represent the standard deviation from triplicate experiments. The
significance of the difference between ss-DNA and ds-DNA with non-mutagenic
pairing was tested using the Student’s two-tailed t test. * indicates p-value <0.05 and
** indicates p-value <0.01.
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TABLES
Table 1. Initial velocity measurements of AlkB on the four DNA substrates in ss- and
perfect match ds-DNA. Each reaction was carried out in triplicate. The significance
of the difference between ss- and ds-DNA reactions was tested using the Student’s
two-tailed t test. The p-values are statistically significant.
ss-DNA [μM·min1
]

ds-DNA [μM·min1
]

p-value

m1A

1.17 ± 0.05

1.03 ± 0.02

0.012

m3C

1.13 ± 0.01

0.84 ± 0.02

<0.001

m1G

0.57 ± 0.03

0.88 ± 0.02

<0.001

m3T

0.03 ± 0.01

0.10 ± 0.01

0.001
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Table S1. Calculated and observed monoisotopic molecular weight and m/z value of
oligonucleotides present in the enzyme repair reactions. The sequence of the 16mer
oligos is 5’-GAAGACCTXGGCGTCC-3’, where X indicates the position of the
lesions and the repaired products.

The sequence of the 17mer oligos is 5’-

TGGACGCCYAGGTCTTC-3’, where Y represents the position incorporating the
complementary bases.

16mer m1A

MW (calculated) of
neutral species
4902.88

m/z (calculate)
-4 charge peak
1224.71

m/z (observed)
-4 charge peak
1224.71

16mer m3C

4878.87

1218.71

1218.70

16mer m1G

4918.87

1228.71

1228.70

16mer m3T

4893.87

1222.46

1222.45

16mer A

4888.86

1221.21

1221.20

16mer C

4864.85

1215.20

1215.20

16mer G

4904.86

1225.21

1225.20

16mer T

4879.85

1218.95

1218.96

17mer A

5183.90

1294.97

1294.96

17mer C

5159.88

1288.96

1288.96

17mer G

5199.89

1298.97

1298.95

17mer T

5174.88

1292.71

1292.71

Lesion or base
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Table S2. Repair efficiency of the three enzymes on four lesions (Figure 3). Each
repair reaction was carried out in triplicate.
AlkB repair of indicated lesion in ss-DNA and ds-DNA.
Lesion

Repair ratio in ss-DNA and ds-DNA (%)
ss-DNA

lesion+A

lesion+C

lesion+G

lesion+T

m1A

53.4 ± 1.5

52.7 ± 4.0

39.0 ± 0.2

40.3 ± 1.1

21.8 ± 1.4

m3C

79.0 ± 1.2

81.4 ± 0.8

70.3 ± 1.7

67.1 ± 1.4

65.8 ± 1.4

m1G

48.2 ± 1.1

50.0 ± 0.3

69.2 ± 0.9

43.7 ± 1.8

55.5 ± 0.5

m3T

12.0 ± 0.4

21.0 ± 0.5

27.8 ± 0.3

12.5 ± 0.0

16.8 ± 0.5

ABH2 repair of indicated lesion in ss-DNA and ds-DNA.
Lesion

Repair ratio in ss-DNA and ds-DNA (%)
ss-DNA

lesion+A

lesion+C

lesion+G

lesion+T

m1A

64.5 ± 1.4

98.3 ± 0.2

96.7 ± 1.0

78.7 ± 1.5

77.9 ± 1.2

m3C

59.7 ± 0.6

93.5 ± 0.4

84.2 ± 0.5

88.8 ± 1.2

54.0 ± 0.3

m1G

22.2 ± 0.7

70.9 ± 0.6

62.3 ± 1.2

44.7 ± 0.7

70.7 ± 1.5

m3T

15.9 ± 1.2

94.1 ± 0.9

92.5 ± 0.7

93.5 ± 0.4

93.3 ± 0.8

ABH3 repair of indicated lesion in ss-DNA and ds-DNA.

Lesion

Repair ratio in ss-DNA and ds-DNA (%)
ss-DNA

lesion+A

lesion+C

lesion+G

lesion+T

m1A

72.0 ± 1.5

13.0 ± 0.7

51.3 ± 2.2

9.8 ± 0.8

9.1 ± 0.5

m3C

57.0 ± 0.4

13.6 ± 0.2

45.2 ± 1.1

10.5 ± 0.5

20.9 ± 0.2
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Table S3. Enzyme concentrations of the three enzymes in the repair reactions. For
each repair reaction, 5 μM 16mer DNA oligo and the corresponding concentration of
the enzyme in this table were used. * the repair efficiencies of ABH3 on m1G and
m3T were extremely low and the products were undetectable even with addition of
large excess amount of the enzyme, such as adding 5μM enzyme to 5μM DNA
adducts.
lesion

AlkB (μM)

ABH2 (μM)

ABH3 (μM)

m1A

0.25

0.31

0.63

m3C

0.08

0.31

0.40

m1G

0.75

5.00

-*

m3T

1.50

1.25

-*

Table S4. Enzyme concentrations of AlkB in the reactions of measuring the initial
velocity. For each repair reaction, 5 μM 16mer DNA oligo and the corresponding
concentration of AlkB in this table were used.
Lesion

AlkB (μM)

m1A

0.1

m3C

0.035

m1G

2.0

m3T

1.5
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Table S5. Repair efficiency of the AlkB enzyme on four lesions with additional 15μM
unrelated 23mer DNA. The ds-DNA reactions were carried out with the perfect match
base pairs of each adduct. The corresponding concentrations of AlkB were listed in
the table. Each repair reaction was carried out in triplicate.
lesion

ss-DNA (%)

ds-DNA (%)

p-value

AlkB (μM)

m1A

56.8 ± 5.5

33.0 ± 0.7

0.016

0.50

m3C

31.3 ± 0.2

28.8 ± 1.3

0.028

0.15

m1G

40.3 ± 1.6

49.8 ± 4.4

0.024

2.25

m3T

13.7± 0.4

41.9 ± 0.8

<0.001

4.50
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ABSTRACT
Hydrolysable tannins are a class of polyphenolic compounds commonly found in
natural products. In this work, we studied the in vitro inhibitory mechanism of six
molecules in this class on ALKBH2, an Fe(II)/α-ketoglutarate-dependent DNA repair
enzyme in the AlkB family. We determined the IC50 values of these compounds on
the repair of 3-methylcytosine, the prototypical substrate of ALKBH2. A structureactivity relationship was also observed between the strength of inhibition and the
number of galloyl moieties in a molecule. In addition, we found that the inhibition by
this class of polyphenolic compounds on ALKBH2 occur through an iron-chelating
mechanism.
INTRODUCTION
Hydrolysable tannins including ellagitannins and gallotannins are a class of
polyphenolic compounds that are commonly found in variety of fruits and plants, such
as berries and oak barks.1,2 These molecules share a general structural motif of galloyl
group(s) and they have been shown to exhibit many health benefits including
antioxidative, antiproliferative, and neuroprotective effects.3 Recent studies have
revealed the involvement of hydrolysable tannins, as iron chelators, in mitigating ironoverload induced hepatotoxicity and neurological disorders.4 Despite the positive
effects, concerns have been raised on the safety of overconsumption of natural
products containing hydrolysable tannins, especially with the lack of evidence in the
relationship between cellular uptake of these compounds and activity of many ironrelated enzymes. There are about 80 Fe(II)/α-ketoglutarate (αKG)-dependent enzymes
in human body, including TET, JmjC and AlkB family proteins.5 In this paper, we
93

focus on the DNA repair enzyme ALKBH2 in the AlkB family, which use
Fe(II)/αKG-dependent mechanism to repair alkyl nucleic acid lesions induced by
endogenous and environmental alkylating agents (Figure 1a).6,7
The AlkB family proteins include nine human homologs (ALKBH1-8 and FTO),
among them ALKBH2 has been identified as the major repair enzyme to lesions in
both ss- and ds-DNA, and ALKBH3 has activity mainly on lesions in ss-DNA.5,6 A
number of alkyl substrates have been reported for the AlkB enzymes including 3methylcytosine

(m3C),

1-methlyadenine

(m1A),

1,N6-ethenoadenine,

3,N4-

ethenocytosine, and other alkyl adducts on the DNA bases. Among these adducts,
m3C and m1A have been demonstrated as the best substrates of AlkB.6,8 Considering
the important role of the AlkB enzymes in maintaining genome integrity and the
previous observations of hydrolysable tannins as metal chelators,, we questioned
whether hydrolysable tannins could affect the activity of the AlkB proteins by
chelating the cofactor Fe(II) ion. In this study, we investigated the potential of six
hydrolysable tannins (structures 2 to 7, Figure 1b), as a new class of inhibitor to the
AlkB enzymes. We extracted and purified a series of ellagitannins and gallotannins to
evaluate their inhibitory effects on the repair efficiency of m3C by the ALKBH2
protein by removing the Fe(II) ion cofactor in the enzymatic reaction. In addition, we
observed a structure-activity relationship between the strength of inhibition and the
number of galloyl groups in these hydrolysable tannins. Our results offer a new
perspective into the potential effect of overtaking hydrolysable tannins that could lead
to the inhibition of iron-dependent enzymes, which will be confirmed by in vivo
studies with the consideration of bioavailability and metabolism.
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EXPERIMENTAL PROCEDURES
DNA synthesis. Sixteen-mer oligonucleotides with the sequence of 5’GAAGACCTXGGCGTCC-3’,

where

X

designates

3-methylcytosine,

were

synthesized by applying automated solid-phase phosphoramidite chemistry on a
Mermade-4 DNA synthesizer.9 The concentration of oligos was measured by
NanoDrop (Thermo Scientific) under UV absorbance of 260 nm. The extinction
coefficient (ε) of 3-methylcytosine lesion is calculated as its unmodified counterpart
due to the negligible value difference in a 16mer context. All the oligos were purified
by reverse-phase HPLC with a Phenomenex Luna Semi-Preparative (10 × 250 mm, 5
μm) C18 column. The solvent A was 100 mM 1:1 triethylamine-acetic acid (TEAA)
and B was 100% acetonitrile. The oligos were characterized by LC-ESI-TOF-MS (AB
Sciex) under negative ionization mode, the liquid chromatographic separation was
conducted using a Phenomenex Luna C18 column (4.6 × 100 mm; 5 μm) at a flow rate
of 0.4 mL/min. Solvent A was 10 mM ammonium acetate in water, and solvent B was
100% acetonitrile.
Protein purification. The ALKBH2 protein was expressed and purified as
previously described.10 Briefly, the ALKBH2 gene was cloned into the pET28a+
vector and then transformed into E. coli BL21 (DE3) pLysS cells for expression. The
his-tagged proteins were purified by affinity column chromatography using FPLC (GE
healthcare). Thrombin was added to digest His-tagged proteins overnight followed by
further purification using ion-exchange chromatography. The purified ALKBH2
proteins were stored in ALKBH buffer containing 300 mM NaCl, 10% glycerol, 50
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mM N-[tris(hydroxymethyl)methyl]-3-aminopropanesulfonic acid and 1 mM 2mercaptoethanol under pH 8.0.
Enzymatic assay and Inhibition mechanism study. For the enzyme inhibition
studies, 5 μM of single-stranded m3C DNA oligonucleotides were incubated with 1.25
μM of ALKBH2 proteins in 46.5 mM HEPES buffer (pH8.0) containing 50 μM αKG,
5 μM Fe (NH4)2(SO4)2 and 1.86 mM ascorbic acid in a 20 μL reaction volume at
37°C for 1 hour.2 To test the IC50 values, the concentrations of hydrolysable tannins
used were optimized individually to achieve the inhibition percentages between range
of 0% to 100%. For the inhibition mechanism studies, the concentration of αKG was
fixed to 93 μM, and different concentrations of Fe (NH4)2(SO4)2 (5, 10, 20, 40, 80
μM) were used for Fe(II) chelator test. In contrast, varying concentrations of αKG (50,
100, 200, 400, 800 μM) and fixed 10 μM of Fe (NH4)2(SO4)2 were used for the αketoglutarate competitor test. The enzyme activity was inactivated by adding 10mM
EDTA followed by heating up to 95°C for 5 min. The analyses were performed by
HPLC and all data represent the mean (± standard deviation, SD) of three independent
experiments.
HPLC analysis. m3C and its repaired product C were analyzed by using a
DNApac PA-100 anion-exchange column (4 x 250 mm, 13 μm) with solvent A as
water and solvent B as 1.5 M ammonium acetate in water. The flow rate was at 1.0
mL/min. A solvent gradient was carried out under the following conditions: 60% of B
for 6 min, 60%-80% for 0.5 min, 80% for 1 min, 80%-60% for 0.5 min, 60% for 4
min.
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Materials. Rhein (1), gallic acid (2), ellagic acid (3) and tannic acid (7) were
purchased from Sigma-Aldrich Chemical Co. (St. Louis, MO, USA). Ellagitannin
(punicalagin 6) was isolated from a commercially available pomegranate extract
(PomellaTM) provided by Verdure Sciences (Noblesville, IN, USA) using our
previously reported methods.11 Gallotannins including ginnalin A (4) and pentagalloyl
glucose (5) were isolated from a red maple leaves extract and sumac fruit extract,
respectively, as we previously reported.12,13
RESULTS AND DISCUSSION
To test the inhibitory effects of hydrolysable tannins on ALKBH2, 16mer
oligonucleotides bearing a site-specific m3C adduct, the primary substrate of
ALKBH2, were synthesized by using solid-phase phosphoramidite chemistry.9,14 The
recombinant human ALKBH2 protein was expressed and purified according to
previous studies.10,15 Then the repair efficiency of ALKBH2 on m3C was assessed.
For the enzymatic reactions, the m3C-containing oligonucleotides were incubated with
ALKBH2 in the presence of two cofactors (αKG and Fe(II) ion) and other necessary
reagents and buffers (see Experimental section in SI for details), and the repair ratio of
m3C was quantified by HPLC after reaction. We used 5.0 μM DNA and 1.25 μM
ALKBH2 for a typical enzymatic reaction to test the inhibition of different
compounds, these concentrations are similar to the conditions previously reported.15
The IC50 values of the six hydrolysable tannins on inhibition of ALKBH2 were
determined. We prepared these compound as previously reported.11,12,16

Rhein

(compound 1, Figure 1b), a well-known inhibitor to the AlkB family enzymes was
served as a positive control.17 The concentrations of rhein varied from 0 to 150 µM
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and the IC50 was found as 42.0 μM (Figure S1), which is comparable to the values on
inhibiting AlkB and FTO reported by Li et al.17 For the hydrolysable tannins, the
concentrations were tested between 0 and 80 µM (Figures S2 to S7). The IC50 values
of compound 2 to 7 were found from 3.9 to 38.2 μM (Table1 and Figures S2 to S7).
Interestingly, based on the structures of these hydrolysable tannins, we found a
correlation of their structural features to their IC50 values: as the number of galloyl
group in the molecule increases, the IC50 value decreases (Table 1). For example, the
one galloyl unit containing compound 2 has IC50 38.2 μM, the five galloyl unit
containing compound 5 has IC50 18.9 μM, and the ten galloyl unit containing
compound 7 has IC50 3.9 μM. Compounds 3 and 4 have two galloyl units and they
have similar IC50 values (25.5 and 22.6 μM, respectively). These results indicate that
the basic galloyl unit of these derivatives are potentially the structural motif
responsible for the inhibitory effects.
We further explored the inhibition mechanism of compounds 1 to 7 on the DNA
repair by ALKBH2. Previously, rhein has been reported as an inhibitor to AlkB and
FTO by competitively replacing αKG in the active site.17,18 And hydrolysable tannins,
including tannic acid (compound 7), have been reported to ameliorate Fe(II) ion and
reactive oxygen species induced neurological diseases.19 In addition, tannic acid has
been reported to mitigate iron-overload by its chelating ability through the neighboring
phenol hydroxyl groups.4 We wanted to investigate the inhibitory mechanisms of the
hydrolysable tannins and chose tannic acid because of its reported activities and the
most galloyl groups possessed in the molecule.
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We varied the concentration of αKG and Fe(II) ion in the reactions without any
inhibitor, and with rhein or compound 7. For the reactions without the inhibitor, small
variations on the reactivity were found with αKG changing from 50 to 800 µM (89%
to 99%, control in Figure 2a) and Fe(II) ion changing from 5 to 80 µM (staying around
93%, control in Figure 2b).

First we tested the reactivity change with different

concentrations of αKG with a fixed Fe(II) ion concentration of 10 µM. When 50 µM
of rhein was added to the reaction media, we found the repair ratio decreased to 30%
with 50 µM αKG. As the amount of αKG increased up to 800 µM, the repair
efficiency was recovered in a concentration-dependent manner (Figure 2a). Then we
tested the reactivity change with different concentrations of Fe(II) ion (from 5 to 80
µM) with a fixed αKG concentration of 93 µM. The reactions with 50 µM rhein all
had repair efficiency around 36% and showed no significant change even with the
increment of Fe(II) ion to 80 µM (Figure 2b). These observations are consistent with
previously reported data of rhein and show that it is a competitive inhibitor to αKG but
not an Fe(II) ion chelator.17,18 For compound 7 under variable concentrations of αKG,
all of the reactions with 2 µM of it had a decreased repair efficiency around 25% and
did not vary significantly with the increment of αKG even to 800 µM (Figure 2a,
Fe(II) ion kept at 10 µM). For the reactions with varying concentrations of Fe(II) ion,
the reactivity was decreased to 5% with 5 µM Fe(II) ion and was restored in a
concentration-dependent manner as Fe(II) ion stepwisely increased up to 80 µM
(Figure 2b, αKG kept at 93 µM). These data indicate that compound 7 is an Fe(II) ion
chelator but not a competitive inhibitor to αKG.
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In this study, we investigated hydrolysable tannins as a new class of natural
product inhibitors for ALKBH2, the major human DNA repair enzyme in the AlkB
family. Hydrolysable tannins have been identified as antioxidative, antiproliferative
and neuroprotective agents. Here, we discovered that these compounds are Fe(II) ion
chelators that can decrease the level of free Fe(II) ion, which is critical for the catalytic
activity of the AlkB family enzymes. At a concentration higher than the Fe(II) ion
level, the reactivity of the AlkB enzymes might be inhibited. It is possible that the
overconsumption of hydrolysable tannins may affect iron homeostasis in the body
leading to the dysfunction of iron-dependent proteins, such as the AlkB homologs and
other Fe(II)/αKG-dependent enzymes. Further studies are necessary to confirm these
observations.
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FIGURES

Figure 1. Repair mechanism of the AlkB family enzymes and structures of the
hydrolysable tannins and rhein.
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Figure 2. Inhibition of ALKBH2 repair reactions by tannic acid and rhein (control: no
inhibitor added).
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Figure S1. Data for determining the IC50 value of compound 1 (Rhein).

Figure S2. Data for determining the IC50 value of compound 2 (gallic acid).
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Figure S3. Data for determining the IC50 value of compound 3 (ellagic acid).

Figure S4. Data for determining the IC50 value of compound 4 (ginnalin acid).
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Figure S5. Data for determining the IC50 value of compound 5 (pentagalloyl glucose).

Figure S6. Data for determining the IC50 value of compound 6 (punicalagin).
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Figure S7. Data for determining the IC50 value of compound 7 (tannic acid).

TABLES
Table 1. IC50 values of hydrolysable tannins inhibiting the ALKBH2 enzyme.
compound
2
3
4
5
6
7

IC50 (µM)
38.2
25.5
22.6
18.9
8.1
3.9
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galloyl units
1
2
2
5
6
10
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ABSTRACT
Reducing sugars non-enzymatically glycate proteins and nucleic acids to form
glycation adducts. Previously, glucose and glucose-6-phosphate have been shown to
glycate lysine residues of protein to form Amadori adducts. As a glycating agent with
multiple-fold higher reactivity and much more abundant cellular concentration than
glucose, glucose-6-phosphate has been proposed to glycate DNA and cause
genotoxicity. Due to the unstable nature of the Amadori adducts and the presence of
cellular DNA repair pathways, it is challenging to study their toxic and mutagenic
properties in cell. Therefore, the specific biological outcomes of these adducts remain
unclear. In this work, we used chemical and genetic approaches to study the biological
consequences, such as replication block and mutations, of Amadori DNA adducts in a
site-specific manner. Our data showed that Amadori DNA adducts arising from
glucose-6-phosphate on dG can induce G to T and single nucleotide deletion, which
may lead to devastating biological consequences if left unrepaired.
INTRODUCTION
Reducing sugars and their metabolic derivatives (e.g. glucose, glucose 6phosphate, methylglyoxal, and glyoxal) can nonenzymatically react with free amino
groups of biomacromolecules, such as proteins and nucleic acids, to induce
glycation.1–3 Among these cellular glycating agents, methylglyoxal and glyoxal are
byproducts of sugar metabolism which are considered as toxins, whereas glucose or
glucose 6-phosphate (Glu-6-P) are thought to be non-toxic because they are essential
metabolic intermediates to supply energy and precursors for biosynthetic pathways in
nearly all organisms. Although D-glucose has a high concentration in blood, it is
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mostly phosphorylated to Glu-6-P after it entering cell (Fig. 1). Thus, Glu-6-P is the
most abundant reducing sugar in cell (~ mM level) which can be further elevated
under abnormal metabolic conditions.1,4
Previously, Glu-6-P and glucose have been shown to glycate lysine residues of
protein to form

fructosamine 6-phosphate (FN6P) and fructosamine products,

respectively.5,6 And these adducts are involved in the pathogenesis of many diseases,
such as aging and cardiovascular diseases due to accumulation of the unrepaired
glycated-proteins.2,2

Recent studies showed that protein FN6P and fructosamine

adducts can be repaired by MDP-1/FN3K mechanism, which has been hypothesized as
the major detoxification pathway for Glu-6-P induced protein glycation.7,8

As a

glycating agent with multiple-fold higher activity than glucose, Glu-6-P has been
demonstrated to glycate DNA and lead to cytotoxicity and mutagenesis.

DNA

glycation has been shown to lead to increased cytotoxicity, strand breaks, and
mutation frequency that are thought to be associated with cancer, neurological
disorders, and aging related diseases.9,2 The extent of DNA alternation appears to be
dependent on the type of nucleobase involved in the modification. Among the three
amino group-containing nucleobases, guanine is most vulnerable to glycating agents;
and N2-dG adducts are the primary source of DNA glycation products.2,5
Glu-6-P glycates DNA with the formation of unstable Schiff base, which rapidly
undergoes structural rearrangement and thereby generate an acyclic Amadori product
(N2-Fructosamine 6-Phosphate-Deoxygunosine, N2-FN6P-dG), the acyclic N2-FN6PdG adduct undergoes further ring closure at O-5 with the C-2 carbonyl group to
generate more stable α and β configurations (Fig. 1). Previous cellular study reported
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that elevated intracellular Glu-6-P levels could increase plasmid mutations in
glycolytic mutant bacteria.10 Also, Bucala et al. examined the mutagenic effect of
Glu-6-P-induced adducts in pBR32 DNA plasmid in E. coli, and a number of mutant
plasmids were observed to have undergone gross DNA alterations, including
mutations, insertions and deletions, as well as the development of multiple species
originating from a single cell.11 These studies have demonstrated that DNA glycation
by Glu-6-P can cause damages to genome and lead to mutagenicity. However, with
the complexity of the formation and unstable nature of Glu-6-P glycation adducts as
well as the potential cellular repair mechanisms involved, it is challenging to study the
mutagenic properties of these adducts. However, with the complexity of the formation
and unstable nature of Glu-6-P glycation adducts as well as the potential cellular repair
mechanisms involved, it is challenging to study the mutagenic properties of these
adducts. For these reasons, the exact biological consequences of glycation DNA
adducts from Glu-6-P are still unclear.
In this paper, we used chemical and genetic methods to study the biological
consequences, such as replication block and mutagenesis, of these glycation adducts in
a site-specific manner. We chemically synthesized N2-FN6P-dG adducts and sitespecifically incorporated them into single-stranded M13 vectors, ant the cytotoxic and
mutagenic properties of the adducts were determined in E. coli cells. Our results, for
the first time, revealed that N2-FN6P-dG adducts cause strong DNA replication block
as well as significant amount of G → T and single nucleotide deletion mutations in
cell. These observations indicate that FN6P DNA glycation products arising from Glu-

114

6-P could lead to genome instability if left unrepaired, thereby affecting the genome
integrity of organisms.
EXPERIMENTAL PROCEDURES
Chemical Synthesis and Characterization of N2-FN6P-dG Glycation
Products.

Thirteen-mer unmodified oligonucleotides with the sequence 5’-

TTTTTTGTTTTTT-3’ were synthesized by using solid-phase phosphoramidite
chemistry on a DNA synthesizer (Bioautomation). The sequence was designed to
harbor only one guanine base to ensure the site-specific incorporation of N2-FN6P-dG
glycation adduct. A concentration of 200 µM 13mer oligos was incubated with 1 M of
D-Glucose 6-phosphate (Roche) under physiological conditions (pH 7.4 in PBS buffer
at 37 °C) for 14 days, two major N2-FN6P-dG products were observed. Studies have
shown that the glycation process was accelerated under elevated pH and temperature
1,12

. An optimized reaction condition (pH 9.5 in 0.1 M sodium borate buffer at 80 °C)

was used to shorten the reaction time (12 h) and increase the yield of glycation
products, two N2-FN6P-dG products were observed with HPLC retention time and
MW matching the two glycation products formed under physiological conditions. The
resulting two N2-FN6P-dG glycation products were separated and purified by a
DNAPac PA100 anion-exchange oligonucleotide column (13 µm, 22 x 250 mm,
Thermo Scientific) with two solvents. Solvent A was water, and solvent B was 1.5 M
ammonium acetate. The purified glycation products were characterized by highresolution triple-TOF MS (AB Sciex).
Construction of M13 Vectors Containing Site-Specific Incorporation of N2FN6P-dG Adducts.

The M13mp7(L2) viral genomes were prepared with site115

specific incorporation of N2-FN6P-dG or adduct-free N2-dG by following the
procedures adopted from Delaney and Essigmann.13 Specifically, 1000 pmol of 13mer
adduct carrying ss-oligos (5’-TTTTTTXTTTTTT-3’, where “X” designates N2-FN6PdG or N2-dG) and 1050 pmol of 21mer barcode ss-oligos (1st barcode sequence: 5’TACCGTCGBBBCGCGCATGCA-3’,

and

2nd

barcode

sequence:

5’-

TCTCGAGTGBBBCGTCAGCAC-3’, where BBB serves as the barcode location for
next-generation sequencing purpose that was not applied in this work) were 5’phosphorylated in a 50 µl solution containing 1mM ATP, 1×T4 polynucleotide kinase
buffer, and 30 units of polynucleotide kinase at 37 °C for 1 h. The 5’-phosphorylated
13mer strand and two 21mer strands were annealed with two scaffolds (1100pmol of
15mer Scaffold I: 5’-GCGCGTACGTAAAAA-3’, and 1100pmol of 14mer Scaffold II:
5’-AAAAAAGAGCTCAC-3’) and further elongated into a 55mer strand by using
1200 units of T4 DNA ligase at 16 °C for 3 h. The ligated 55mer oligos were purified
by 15% PAGE-urea gel and the concentration was quantified by UV absorbance
measurement at 260 nm. The ligated 55mer oligos (75 pmol) were annealed with 30
pmol of ss-M13mp7(L2) vectors (linearized by XX units of EcoRI at XX °C for XX h)
in the presence of two scaffolds (48 pmol of 28mer Scaffold III: 5’CGATACTGGTACTAAGTCACATGGCAGC-3’, and 48 pmol of 29mer Scaffold IV:
5’-GCAGTCGTGTTAAGTGACCGGCAGCAAAA-3’) and then ligated by T4 ligase
at 16 °C for 12 h. 20units λ exonuclease and 30 units of RecJf exonuclease were
subsequently added to the resulting mixture and incubated at 37 °C for 5 h. The
mixture was extracted with phenol/chloroform/isoamyl alcohol (25/24/1, vol), and the
aqueous phase was precipitated by 100% ethanol and the DNA pellet (genome) was
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resuspended in nuclease-free water. The constructed genomes were normalized against
an adduct-free competitor genome ligated with a 58mer competitor strand (by
inserting a 16mer ss-oligo: 5’-TTTTTTGTTTTTTTTT-3’).
Transfection of E. coli Cells with M13 Vectors Containing N2-FN6P-dG
adducts. The electrocompetent AB1157 E. coli cells were electroporated (at 2.5kV)
with M13 genomes containing N2-FN6P-dG or adduct-free N2-dG which were premixed with the competitor genomes at a ratio of 4:1. The E. coli cells were then
transferred into 1 ml SOC medium and incubated at 37 °C for 1 h followed by
transferring into 10 ml LB medium for an additional incubation of 6 h, after which the
resulting phages were collected from the supernatant of culture medium by
centrifuging at 4700 rpm for 15 min. The phages were further amplified by SCS110 E.
coli cells to increase the progeny genome percentage over adduct-carrying genomes.
The final amplified phages were recovered by centrifuging at 4700 rpm for 15 min,
and the M13 genomes were extracted with a QIAprep 2.0 spin column by following
manufacturer’s guidance.
LC-MS Based Bypass Efficiency and Mutation Frequency Assays. A
competitor gapped plasmid (with a ligation of 16mer oligonucleotide 5’TTTTTTGTTTTTTTTT-3’) with three bases longer than the adduct-containing
plasmid was used as an internal control.

The resulting progeny genomes after

replication were extracted according to the instruction of QIAGEN DNA extraction kit.
The region of interest in the genome was amplified with two primers (Primer F: 5'GCTATGACCATGATTCAGTGTACCGTCG-3', Primer R: 5'-AAAACGACGGCC
AGTGAATTGTGCTGACG-3') by PCR.
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The PCR products were purified by

QIAquick PCR Purification kit. For the LC-MS analysis, the PCR fragments were
digested with 40 units of Xhol and 30 units of SphI enzymes in 50µL of CutSmart
buffer at 37 °C for 3 h, flowed by heating up to 65 °C for 20 min to deactivate the
restriction enzymes. The resulting oligonucleotides were desalted and analyzed by LCMS. The following LC-MS conditions were used: the LC separation was carried out
by using a Thermo Acclaim PolarAdvantage II C18 column (3µm, 2.1 x 250mm); the
flow rate was 100µL; a 5min of gradient of 25% was used to introduce sample
followed by a 30 min of 25%-50% methanol in 400mM HFIP buffer (pH 7.0) for
separation. ESI was conducted by using a needle voltage of 4.0 kV in a negative mode.
The heater was set at 300 °C. The nebulizer gas was 40 psi; the heater gas was 40 psi;
the curtain gas was 25 psi; the declustering potential was −220 V; and the collision
energy was −10 V. For the calculation of bypass efficiency, the formula %bypass =
(adduct oligo signal/competitor signal)/(non-adduct signal/its competitor signal) was
used.
Statistical Analyses. Statistical analysis was conducted by software IBM SPSS
Statistics 23 and Microsoft Excel 2016. Statistical significance for data between two
groups was characterized with a two-tailed Student’s t test. P-values < 0.05 were
considered statistically significant.
RESULTS
Chemical Synthesis and Characterization of N2-FN6P-dG Adducts.

To

synthesize N2-FN6P-dG glycation adducts, we first tested the glycation of DNA under
physiological conditions (37 °C, and pH 7.4 in PBS buffer) by incubating 200 µM of
13mer oligonucleotide (5’-TTTTTTGTTTTTT-3’) with 1 M Glu-6-P for 14 days.
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AEX-HPLC analysis have revealed the formation of two major products (peak1 and 2
in Fig. 2b), which were later characterized as α and β anomers of the N2-FN6P-dG
adducts in the 13mer context. However, the yield of the products was low (less than
10%), which did not meet the amount of material required for the subsequent
biological studies. As the glycation rate of nucleic acids by reducing sugars was
reported to be dependent on two major factors: pH and temperature,12,14 we optimized
the reaction condition by applying pH 9.5 under 80 °C. We monitored the formation of
glycation products after 8 hours of incubation, and the results showed that the reaction
was greatly accelerated and could be prepared on a large scale (Fig. 2a). We then
conducted the purification for the two glycation products by AEX-HPLC (Fig. 3a),
and the HPLC chromatogram indicated that the two peaks were well separated (Fig. 3c
and 3d). As the glycation process is reversible, we also tested the stability of the two
products by incubating them under physiological conditions for 4 days, some of the
two products (Fig. 3e for peak 1 and 3f for peak 2) were converted back to the starting
material 13mer G (Fig. 3b); these observations are consistent with the previous studies
that the DNA glycation of Amadori products are reversible to unmodified DNA
bases.15 In addition, we compared the reactivity of different nucleobases to Glu-6-P
under the optimized reaction condition. We quantified the glycation products
formation for the 13mer oligos containing dA, dC, dG and dT nucleobase respectively.
The results showed that 13mer G exhibited highest reactivity with 23.1% glycation
conversion after 8 h, whereas 13mer A and 13mer C had only 1.6% and 0.8%, there
was no glycation on dT (Fig. 4).
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After synthesis, we observed the formation of two major glycation adducts (Fig 2,
and Fig 3a) from the incubation of Glu-6-P with DNA oligos. To identify the MW of
the two adducts, the modified oligos were analyzed by high-resolution MS. The
13mer glycated oligo (peak 1 in Fig. 3c) showed a good signal at m/z of 1384.8857 at
the -3 charged envelope of mass spectrum (Fig. 5a). The observed m/z matches the
theoretical calculation of m/z of 1384.8816 for N2-FN6P-dG adduct formation at X
location of the starting material sequence (5’-TTTTTTXTTTTTT-3’). Similarly, we
observed identical MW for the second glycation adduct (peak 2 in Fig. 3d, MS data
not shown). These results indicated the two glycation products were α and β anomers
from ring closure of Amadori product at O-5 with the C-2 carbonyl group (Fig. 1). To
further confirm the identity of the adducts, we conducted nuclease digestion and
dephosphorylation of the purified N2-FN6P-dG adduct-containing oligos into single
nucleosides, then analyzed the highly hydrophilic adduct-carrying dG by HILIC-LCMS.

By using a combination of DNase I, phosphodiesterase I, and alkaline

phosphatase to digest the 13mer sequence into single nucleosides,16–18 we were able
to observe the digested adduct-modified nucleoside at m/z 430.1647 (positive mode,
+H, 430.1574 for theoretical m/z); this species was generated from the enzymatic
dephosphorylation of N2-FN6P-dG into N2-Fructosamine-dG (Fig. 5b, representative
MS data for peak 1 digestion in Fig. 3c). In addition, no thymidine modifications have
been observed in the 13mer sequence. These observations together supported that the
glycation products were N2-FN6P-dG adducts from Glu-6-P (Fig. 1).
Replication Block and Mutagenicity Assays of N2-FN6P-dG Adducts. We
next determined how the presence of N2-FN6P-dG adducts affect DNA replication,
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and what biological outcomes are involved in polymerase bypassing these adducts in
cell. To this end, we carried out site-specific detection of replication block and
mutagenesis adopted from Essigmann lab

13,19

for the two N2-FN6P-dG adducts. We

ligated the two adduct-containing 13mer oligos into single-stranded M13 vector
respectively (Fig. 6), and tested the bypass efficiency and mutation frequency of them
in E. coli cells. The data obtained from quantitative LC-MS analysis showed adduct-1
with a bypass efficiency of only 22% comparing to unmodified guanine as 100%, and
adduct-2 with a bypass efficiency of 24% (Fig. 7, top). These results indicated that the
N2-FN6P-dG adducts are strong blocks to DNA replication. We subsequently
quantified the mutation frequency of the two adducts, adduct 1 (Fig. 7, bottom)
exhibited strong G to T mutation (26%) and -1 deletion of dG base (30%). Similarly,
adduct-2 had G to T mutation of 16% and -1 deletion of dG of 36%. These results
demonstrated that N2-FN6P-dG adducts can cause strong mutagenicity.
DISCUSSION
Glu-6-P is an important glycolysis intermediate which constitutes a dominant
endogenous reducing sugar metabolite. Previous studies on its cellular glycation
outcomes demonstrated that the dysregulation of Glu-6-P is associated with
genotoxicity including insertion, deletion, and point mutations10,11. However, neither
the exact mutation patterns of the glycation nor the specific identity of these glycation
adducts were assessed. This is challenging presumably that, first, cellular glycation
process is complex due to the many types of glycation adducts formed; second, most
of these adducts are unstable and could be only existed in transition state; third,
several competing DNA repair pathways are involved in removing these adducts. To
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this end, we chemically synthesized and characterized the DNA glycation adducts
arising from Glu-6-P to confirm their identity. Furthermore, their stability was
evaluated and proper assays were accommodated to test their biological consequences
during DNA replication.
Cellular DNA replication study using M13 vector with site-specific incorporation
of N2-FN6P-dG adducts revealed that the two anomers exhibited strong block (22%
and 24% bypass respectively) to polymerase comparing to dG (100% bypass). This
result suggests that the two bulky FN6P adducts are poorly tolerated by replication and
translesion polymerases, and the two glycation adducts occurring at N2 of WatsonCrick base paring face of dG may impose a large steric hindrance to DNA replication.
On the other hand, our mutagenicity test demonstrated that the two N2-FN6P-dG
adducts induced significant G to T and single nucleotide deletion mutations (26% G
→T, 30% -1 G for adduct-1, 16% G →T, 36% -1 G for adduct-2) comparing to dG (no
mutations detected). These observations indicate the bypass of the two glycation
adducts by polymerase is error-prone and in a low fidelity manner. Previously, Yuan
et al. have identified methylglyoxal induced N2-carboxyethyl-dG DNA glycation
adducts are weakly mutagenic and only lead to minor G to T mutation (<3%); besides,
they have found that the bypass of these adducts are well tolerated by DinB
(polymerase IV) in E. coli cells2. There are a number of previous findings that DinB
is capable of bypassing many N2-dG adducts13,20–22, we doubted that this polymerase
may also be involved in bypassing N2-FN6P-dG adducts. We performed bypass and
mutagenesis studies in ΔdinB (pol IV-deficient) E. coli cells. However, results
obtained from these studies did not show a significant difference of bypass efficiency
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compared to wild-type cells (data not shown). Future experiments in testing other
translesion polymerases, such as pol II and pol V, may provide insights into the
detailed cellular bypass mechanisms on these N2-FN6P-dG adducts.
Taken together, the results presented in current study provide important evidence
showing that N2-FN6P-dG adducts arising from Glu-6-P, could lead to strong
replication block and mutagenicity if left unrepaired, thereby affecting the genome
integrity of organisms. In addition, Glu-6-P, cellular fructose 6-phosphate (Fru-6-P,
µM level) and ribose 5-phosphate (Rib-5-P, µM level) are also highly reactive
glycating agents.23 The two molecules are 1260 fold for Fru-6-P and 1878 fold for
Rib-5-P more powerful than glucose for glycating DNA.24 The deleterious biological
effects generated from these reducing sugar metabolites may represent a unique
perspective to study mutagenesis of endogenous molecules.
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FIGURES

Figure 1. DNA glycation adducts generated from glucose 6-phosphate and their
biological implications in cell replication and diseases.
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Figure. 2. HPLC separations of glycation oligos generated under a) optimized
condition and b) physiological condition.

Figure. 3. Separations of DNA oligos by AEX-HPLC. a) reaction mixture, b) 13mer
starting material, c) purified adduct-1, d) purified adduct-2, e) adduct-1 and f) purified
adduct-2 incubated under 37 ℃ and pH 7.4 for 4 days.
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Figure. 4. Glycation adduct formation on four nucleobases.

Figure. 5. ESI-TOF analysis of a) the N2-FN6P-dG containing 13mer oligo; b) N2FN6P-dG

nucleoside

product

generated

dephosphorylation.
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Figure. 6. Genome construction of vectors containing glycation adducts for E. coli
assays.

Figure. 7. In cell demonstration of the bypass (top) and mutagenicity (bottom) of the
glycation adducts.
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